WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/whitehead-institute-for-biomedical-research-061043412. Retrieved 2026-11-15.
APA furp.org. (n.d.). WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 15, 2026, from https://furp.org/org/whitehead-institute-for-biomedical-research-061043412
MLA “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH.” furp.org, tax years 2009–2024, https://furp.org/org/whitehead-institute-for-biomedical-research-061043412. Accessed 15 Nov. 2026.
Retrieved 2026-11-15; covers tax years 2009–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
About (Wikipedia)
Whitehead Institute · Non-profit biomedical research institute
Whitehead Institute for Biomedical Research is a non-profit research institute located in Cambridge, Massachusetts, United States, that is dedicated to improving human health through basic biomedical research.
- Founded
- 1982
- Type
- biological research institute, facility
- Website
- https://wi.mit.edu/
From Wikipedia, CC BY-SA 4.0 (authors and history); facts from Wikidata (CC0). Matched by the same website address and the same name. Report a wrong match · About this data
2024 · Form 990 · revenue $222.3M ($228.1M in 2025 dollars) · expenses $174.3M · assets $973.2M
- EIN
- 06-1043412
- Address
- 455 MAIN ST, CAMBRIDGE, MA 02142-1025
- Website
- WWW.WI.MIT.EDU
- NTEE code
- H92 Biomedicine, Bioengineering Research (Medical Research) published (IRS Business Master File)
- FURP topic
- science: research education (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- June 2018 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Public charity supported by the public (170(b)(1)(a)(vi))
- Cross-check
- ProPublica Nonprofit Explorer
Mission
WHITEHEAD INSTITUTE FORGES NEW FRONTIERS IN SCIENCE, UNCOVERING INSIGHTS TODAY THAT UNLOCK THE POTENTIAL OF TOMORROW. OUR ADVANCES IN GENETICS AND GENOMICS ARE NOW ENABLING US TO TACKLE THE COMPLEXITIES OF LIFE WITH UNPRECEDENTED DEPTH AND BREADTH.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
23 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Mr Martin Mullins | VICE PRESIDENT | 2009-2024 | $598,203 | $7,410,417 | 1 |
| Dr Rudolf Jaenisch | MEMBER (FACULTY) | 2009-2024 | $455,943 | $5,800,353 | 1 |
| Dr Robert Weinberg | MEMBER (FACULTY) | 2009-2024 | $426,772 | $4,886,330 | 1 |
| Dr Ruth Lehmann | DIRECTOR/PRESIDENT | 2020-2024 | $1,081,921 | $4,560,540 | 1 |
| Dr Richard Young | MEMBER (FACULTY) | 2016-2024 | $429,743 | $3,398,632 | 1 |
| Ms Sharon Stanczak | VP & SECRETARY (END 12/2024) | 2018-2024 | $500,911 | $3,097,035 | 1 |
| Ms Laura Sander | CFO & TREASURER | 2010-2024 | $473,626 | $2,303,291 | 1 |
| Dr Iain Cheeseman | MEMBER (FACULTY) | 2020-2024 | $422,270 | $1,822,443 | 1 |
| Harvey Lodish PhD | MEMBER (FACULTY) | 2020-2024 | $385,142 | $1,427,778 | 4 |
| Ms Monica Gerber | SECRETARY (FORMER) | 2018-2024 | $148,409 | $1,018,710 | 1 |
| Ms Monique Taylor | ASST SECRETARY | 2022-2024 | $108,740 | $249,692 | 1 |
| Dr David Page (former) | DIRECTOR/PRESIDENT (FORMER) | 2009-2020 | $397,250 | $4,696,897 | 1 |
| Dr Gerald Fink (former) | MEMBER (FACULTY) | 2009-2017 | $377,236 | $3,113,482 | 1 |
| Dr Hidde Ploegh (former) | MEMBER (FACULTY)- END 12/2016 | 2009-2016 | $363,871 | $2,527,663 | 1 |
| Dr Terry Orr-Weaver (former) | MEMBER (FACULTY) | 2010-2017 | $341,330 | $2,114,062 | 1 |
| Dr Hazel Sive (former) | MEMBER (FACULTY) | 2009-2019 | $427,350 | $1,674,443 | 1 |
| Ms Julia Fantasia (former) | CFO & TREASURER (END 08/2022) | 2017-2022 | $243,867 | $1,633,055 | 1 |
| Ms Caroline Romano (former) | ASST SECRETARY | 2012-2020 | $93,495 | $704,093 | 1 |
| Dr Mary Gehring (former) | MEMBER (FACULTY) | 2023 | $395,540 | $395,540 | 1 |
| Ms Kimberly Forness (former) | ASST SECRETARY(UNTIL DEC 2012) | 2009-2012 | $82,946 | $384,485 | 1 |
| Ms Laura Ketchum (former) | CFO - END 10/17 | 2016-2017 | $259,824 | $351,526 | 1 |
| John Travia (former) | Treasurer (Until 2/5/10) | 2009 | $180,055 | $180,055 | 3 |
| Mr Mark Poirot-Colleary (former) | ASST SECRETARY (END 07/2022) | 2021-2022 | $71,226 | $170,776 | 1 |
Officers and directors, no compensation reported
40 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Mr Seth Alexander | DIRECTOR | 2020-2024 | 2 | $0 reported | 4 |
| Sally Kornbluth | DIRECTOR | 2023-2024 | 2 | $0 reported | 3 |
| Ms Susan Whitehead | DIRECTOR | 2009-2024 | 2 | $0 reported | 2 |
| Ms Brit D'Arbeloff | DIRECTOR (END 5/2025) | 2009-2024 | 2 | $0 reported | 1 |
| Mr Jonathan Goldstein | DIRECTOR | 2009-2024 | 2 | $0 reported | 1 |
| Mr Peter Whitehead | DIRECTOR (END 9/2024) | 2009-2024 | 2 | $0 reported | 1 |
| Dr Robert Satcher | DIRECTOR | 2020-2024 | 2 | $0 reported | 1 |
| Dr Paul Joskow | DIRECTOR/BOARD VICE CHAIR | 2017-2024 | 2 | $0 reported | 1 |
| Ms Sarah Williamson | DIRECTOR/BOARD CHAIR | 2018-2024 | 3 | $0 reported | 1 |
| Dr Dennis Langer | DIRECTOR | 2019-2024 | 2 | $0 reported | 1 |
| Kevin Churchwell MD | DIRECTOR | 2021-2024 | 2 | $0 reported | 13 |
| Mr Michael Chambers | DIRECTOR | 2022-2024 | 2 | $0 reported | 1 |
| Mr Terrance Mcguire | DIRECTOR | 2022-2024 | 2 | $0 reported | 1 |
| Mr Raja Bobbili | DIRECTOR | 2022-2024 | 2 | $0 reported | 1 |
| Dr Deborah Dunsire | DIRECTOR | 2023-2024 | 2 | $0 reported | 1 |
| Ms Micho Spring | DIRECTOR | 2023-2024 | 2 | $0 reported | 1 |
| Ms Maren Winnick | DIRECTOR (START 12/2024) | 2024 | 2 | $0 reported | 1 |
| Dr Mark Lapman (former) | DIRECTOR | 2009-2023 | 2 | $0 reported | 1 |
| Phillip Sharp (former) | DIRECTOR | 2009-2023 | 2 | $0 reported | 2 |
| Mr Churchill Franklin (former) | DIRECTOR | 2019-2023 | 2 | $0 reported | 1 |
| Susan Hockfield (former) | DIRECTOR | 2019-2023 | 2 | $0 reported | 13 |
| Robert Langer (former) | DIRECTOR | 2009-2022 | 2 | $0 reported | 3 |
| Mr John Whitehead (former) | DIRECTOR | 2009-2020 | 2 | $0 reported | 1 |
| Dr Charles Ellis (former) | DIRECTOR/BOARD CHAIR | 2009-2019 | 2 | $0 reported | 1 |
| Dr Andrew Lo (former) | DIRECTOR (END 12/2019) | 2014-2019 | 2 | $0 reported | 1 |
| Dr Arthur Schleifer (former) | DIRECTOR | 2014-2019 | 2 | $0 reported | 1 |
| Ms Amy Schulman (former) | DIRECTOR (END 9/2019) | 2016-2019 | 2 | $0 reported | 1 |
| Mr Michael Bonney (former) | DIRECTOR (END 9/2018) | 2015-2018 | 2 | $0 reported | 1 |
| Mr Arthur Brill (former) | DIRECTOR/SECRETARY | 2009-2017 | 2 | $0 reported | 1 |
| Mr David Koch (former) | DIRECTOR END 3/18 | 2009-2017 | 2 | $0 reported | 1 |
| Dr William Pounds (former) | DIRECTOR (EMERITUS) | 2011-2017 | 2 | $0 reported | 1 |
| The Hon Deval Patrick (former) | DIRECTOR - END 3/18 | 2016-2017 | 2 | $0 reported | 1 |
| Ms Liliana Bachrach (former) | DIRECTOR - END 09/16 | 2014-2016 | 2 | $0 reported | 1 |
| Mr Landon Clay (former) | DIRECTOR | 2009-2014 | 2 | $0 reported | 1 |
| Dr Nancy Rose (former) | DIRECTOR (UNTIL 8/31/2014) | 2009-2014 | 2 | $0 reported | 1 |
| Dr Joshua S Boger (former) | DIRECTOR | 2011-2014 | 2 | $0 reported | 1 |
| Mr Neil Chayet (former) | Director (UNTIL 9/17/2014) | 2010-2014 | 2 | $0 reported | 1 |
| Dr Peter Kim (former) | DIRECTOR | 2009-2013 | 2 | $0 reported | 1 |
| Dr Peter Hecht (former) | DIRECTOR | 2009-2012 | 2 | $0 reported | 1 |
| Dr Barbara Imperiali (former) | Director (Until 9/16/09) | 2009 | 2 | $0 reported | 1 |
People by year
2024 · 28 people listed · 11 paid, $5.0M · 368 employees · 16 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR RUTH LEHMANN | DIRECTOR/PRESIDENT | 40 | $1,031,797 | $0 | $50,124 | $1,081,921 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $548,079 | $0 | $50,124 | $598,203 | 1 |
| MS SHARON STANCZAK | VP & SECRETARY (END 12/2024) | 40 | $427,063 | $0 | $73,848 | $500,911 | 1 |
| MS LAURA SANDER | CFO & TREASURER | 40 | $398,735 | $0 | $74,891 | $473,626 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $391,954 | $0 | $63,989 | $455,943 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $366,154 | $0 | $63,589 | $429,743 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $363,183 | $0 | $63,589 | $426,772 | 1 |
| DR IAIN CHEESEMAN | MEMBER (FACULTY) | 40 | $350,818 | $0 | $71,452 | $422,270 | 1 |
| DR HARVEY LODISH | MEMBER (FACULTY) | 40 | $320,904 | $0 | $64,238 | $385,142 | 4 |
| MS MONICA GERBER | SECRETARY (FORMER) | 20 | $124,659 | $0 | $23,750 | $148,409 | 1 |
| MS MONIQUE TAYLOR | ASST SECRETARY | 40 | $90,114 | $0 | $18,626 | $108,740 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR (END 5/2025) | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR (END 9/2024) | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT SATCHER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL JOSKOW | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS SARAH WILLIAMSON | DIRECTOR/BOARD CHAIR | 3 | $0 | $0 | $0 | $0 | 1 |
| DR DENNIS LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR SETH ALEXANDER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 4 |
| DR KEVIN CHURCHWELL | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MR MICHAEL CHAMBERS | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR TERRANCE MCGUIRE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR RAJA BOBBILI | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SALLY KORNBLUTH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR DEBORAH DUNSIRE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS MICHO SPRING | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS MAREN WINNICK | DIRECTOR (START 12/2024) | 2 | $0 | $0 | $0 | $0 | 1 |
2023 · 31 people listed · 11 paid, $4.7M · 360 employees · 20 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR RUTH LEHMANN | DIRECTOR/PRESIDENT | 40 | $1,007,583 | $0 | $50,055 | $1,057,638 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $533,715 | $0 | $48,017 | $581,732 | 1 |
| MS SHARON STANCZAK | VICE PRESIDENT & SECRETARY | 40 | $422,093 | $0 | $65,577 | $487,670 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $383,687 | $0 | $60,452 | $444,139 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $357,083 | $0 | $60,052 | $417,135 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $352,222 | $0 | $60,052 | $412,274 | 1 |
| DR MARY GEHRING | MEMBER (FACULTY) | 40 | $329,293 | $0 | $66,247 | $395,540 | 1 |
| DR IAIN CHEESEMAN | MEMBER (FACULTY) | 40 | $324,315 | $0 | $65,928 | $390,243 | 1 |
| MS LAURA SANDER | CFO & TREASURER | 40 | $193,664 | $0 | $40,500 | $234,164 | 1 |
| MS MONICA GERBER | SECRETARY (FORMER) | 20 | $121,089 | $0 | $23,154 | $144,243 | 1 |
| MS MONIQUE TAYLOR | ASST SECRETARY | 40 | $88,485 | $0 | $18,095 | $106,580 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT SATCHER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL JOSKOW | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR CHURCHILL FRANKLIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SUSAN HOCKFIELD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MS SARAH WILLIAMSON | DIRECTOR/BOARD CHAIR | 3 | $0 | $0 | $0 | $0 | 1 |
| DR DENNIS LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR SETH ALEXANDER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 4 |
| DR KEVIN CHURCHWELL | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MR MICHAEL CHAMBERS | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR TERRANCE MCGUIRE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR RAJA BOBBILI | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SALLY KORNBLUTH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR DEBORAH DUNSIRE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS MICHO SPRING | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
2022 · 31 people listed · 12 paid, $4.5M · 378 employees · 18 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR RUTH LEHMANN | DIRECTOR/PRESIDENT | 40 | $980,979 | $0 | $46,974 | $1,027,953 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $515,157 | $0 | $44,674 | $559,831 | 1 |
| MS SHARON STANCZAK | VICE PRESIDENT & SECRETARY | 40 | $409,048 | $0 | $61,149 | $470,197 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $372,229 | $0 | $56,653 | $428,882 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $347,377 | $0 | $56,253 | $403,630 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $329,583 | $0 | $56,253 | $385,836 | 1 |
| DR HARVEY LODISH | MEMBER (FACULTY) | 40 | $301,076 | $0 | $59,031 | $360,107 | 4 |
| DR IAIN CHEESEMAN | MEMBER (FACULTY) | 40 | $296,893 | $0 | $62,245 | $359,138 | 1 |
| MS JULIA FANTASIA | CFO & TREASURER (END 08/2022) | 40 | $205,751 | $0 | $38,116 | $243,867 | 1 |
| MS MONICA GERBER | SECRETARY (FORMER) | 20 | $119,198 | $0 | $22,280 | $141,478 | 1 |
| MR MARK POIROT-COLLEARY | ASST SECRETARY (END 07/2022) | 40 | $52,184 | $0 | $19,042 | $71,226 | 1 |
| MS MONIQUE TAYLOR | ASST SECRETARY | 40 | $29,023 | $0 | $5,349 | $34,372 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT SATCHER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL JOSKOW | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR CHURCHILL FRANKLIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SUSAN HOCKFIELD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MS SARAH WILLIAMSON | DIRECTOR/BOARD CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| DR DENNIS LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR SETH ALEXANDER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 4 |
| DR KEVIN CHURCHWELL | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MR MICHAEL CHAMBERS | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR TERRANCE MCGUIRE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR RAJA BOBBILI | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS LAURA SANDER | CFO & TREASURER | 40 | $0 | $0 | $0 | $0 | 1 |
2021 · 26 people listed · 11 paid, $4.4M · 360 employees · 15 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR RUTH LEHMANN | DIRECTOR/PRESIDENT | 40 | $946,997 | $0 | $42,725 | $989,722 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $500,018 | $0 | $42,225 | $542,243 | 1 |
| MS SHARON STANCZAK | VICE PRESIDENT & SECRETARY | 40 | $397,802 | $0 | $57,674 | $455,476 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $351,376 | $0 | $54,800 | $406,176 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $329,593 | $0 | $54,500 | $384,093 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $309,056 | $0 | $62,646 | $371,702 | 1 |
| DR HARVEY LODISH | MEMBER (FACULTY) | 40 | $287,145 | $0 | $56,466 | $343,611 | 4 |
| MS JULIA FANTASIA | CFO & TREASURER | 40 | $273,385 | $0 | $54,620 | $328,005 | 1 |
| DR IAIN CHEESEMAN | MEMBER (FACULTY) | 40 | $260,482 | $0 | $59,573 | $320,055 | 1 |
| MONICA GERBER | SECRETARY (FORMER) | 20 | $122,937 | $0 | $22,070 | $145,007 | 1 |
| MR MARK POIROT-COLLEARY | ASST SECRETARY | 40 | $71,288 | $0 | $28,262 | $99,550 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT SATCHER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL JOSKOW | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR CHURCHILL FRANKLIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SUSAN HOCKFIELD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MS SARAH WILLIAMSON | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| DR DENNIS LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR SETH ALEXANDER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 4 |
| DR KEVIN CHURCHWELL | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
2020 · 27 people listed · 12 paid, $4.2M · 349 employees · 15 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $463,784 | $0 | $41,373 | $505,157 | 1 |
| MS SHARON STANCZAK | VICE PRESIDENT | 40 | $417,084 | $0 | $56,181 | $473,265 | 1 |
| DR RUTH LEHMANN | DIRECTOR/PRESIDENT | 40 | $366,073 | $0 | $37,233 | $403,306 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $346,950 | $0 | $53,221 | $400,171 | 1 |
| DR DAVID PAGE | DIRECTOR/PRESIDENT (FORMER) | 0 | $397,250 | $0 | $0 | $397,250 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $325,220 | $0 | $52,721 | $377,941 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $306,297 | $0 | $59,958 | $366,255 | 1 |
| DR HARVEY LODISH | MEMBER (FACULTY) | 40 | $283,447 | $0 | $55,471 | $338,918 | 4 |
| DR IAIN CHEESEMAN | MEMBER (FACULTY) | 40 | $273,724 | $0 | $57,013 | $330,737 | 1 |
| MS JULIA FANTASIA | CFO & TREASURER | 40 | $259,696 | $0 | $50,469 | $310,165 | 1 |
| DR MONICA GERBER | SECRETARY | 40 | $132,402 | $0 | $22,934 | $155,336 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $78,984 | $0 | $14,511 | $93,495 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT SATCHER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL JOSKOW | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR CHURCHILL FRANKLIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SUSAN HOCKFIELD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MS SARAH WILLIAMSON | DIRECTOR/BOARD CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR DENNIS LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR SETH ALEXANDER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 4 |
2019 · 27 people listed · 10 paid, $3.3M · 347 employees · 15 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $450,112 | $0 | $41,919 | $492,031 | 1 |
| DR HAZEL SIVE | MEMBER (FACULTY) | 40 | $369,011 | $0 | $58,339 | $427,350 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $339,462 | $0 | $53,916 | $393,378 | 1 |
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 40 | $385,679 | $0 | $0 | $385,679 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $320,551 | $0 | $53,164 | $373,715 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $298,323 | $0 | $59,655 | $357,978 | 1 |
| MS SHARON STANCZAK | VP INSTITUTIONAL ADVANCEMENT | 40 | $293,580 | $0 | $56,071 | $349,651 | 1 |
| MS JULIA FANTASIA | CFO & TREASURER | 40 | $251,803 | $0 | $49,836 | $301,639 | 1 |
| DR MONICA GERBER | SECRETARY | 40 | $133,608 | $0 | $23,414 | $157,022 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $76,456 | $0 | $14,329 | $90,785 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ANDREW LO | DIRECTOR (END 12/2019) | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ARTHUR SCHLEIFER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS AMY SCHULMAN | DIRECTOR (END 9/2019) | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL L JOSKOW | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR CHURCHILL FRANKLIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR SUSAN HOCKFIELD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 13 |
| MS SARAH WILLIAMSON | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR DENNIS LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
2018 · 25 people listed · 10 paid, $3.2M · 367 employees · 14 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $436,612 | $0 | $41,115 | $477,727 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $328,778 | $0 | $51,908 | $380,686 | 1 |
| DR HAZEL SIVE | MEMBER (FACULTY) | 40 | $324,582 | $0 | $55,983 | $380,565 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $318,143 | $0 | $57,653 | $375,796 | 1 |
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 40 | $374,446 | $0 | $0 | $374,446 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $311,453 | $0 | $51,558 | $363,011 | 1 |
| MS SHARON STANCZAK | VP Institutional Advancement | 40 | $305,101 | $0 | $54,764 | $359,865 | 1 |
| MS JULIA FANTASIA | CFO & TREASURER | 40 | $252,205 | $0 | $44,741 | $296,946 | 1 |
| DR MONICA GERBER | SECRETARY | 40 | $107,414 | $0 | $19,801 | $127,215 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $74,232 | $0 | $13,902 | $88,134 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ANDREW LO | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ARTHUR SCHLEIFER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS AMY SCHULMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL L JOSKOW | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS SARAH WILLIAMSON | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR MICHAEL BONNEY | DIRECTOR (END 9/2018) | 2 | $0 | $0 | $0 | $0 | 1 |
2017 · 28 people listed · 10 paid, $3.1M · 380 employees · 31 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $434,289 | $0 | $35,251 | $469,540 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $339,789 | $0 | $37,447 | $377,236 | 1 |
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $363,540 | $0 | $0 | $363,540 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $320,239 | $0 | $37,947 | $358,186 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $307,284 | $0 | $39,707 | $346,991 | 1 |
| DR HAZEL SIVE | MEMBER (FACULTY) | 40 | $305,038 | $0 | $37,446 | $342,484 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $305,611 | $0 | $35,719 | $341,330 | 1 |
| MS LAURA KETCHUM | CFO - END 10/17 | 40 | $227,997 | $0 | $31,827 | $259,824 | 1 |
| MS JULIA FANTASIA | CFO & TREASURER (START 11/2017 | 40 | $140,000 | $0 | $12,433 | $152,433 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $74,248 | $0 | $0 | $74,248 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | $0 | $0 | $0 | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR DAVID KOCH | DIRECTOR END 3/18 | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR (EMERITUS) | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ANDREW LO | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ARTHUR SCHLEIFER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR MICHAEL BONNEY | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| THE HON DEVAL PATRICK | DIRECTOR - END 3/18 | 2 | $0 | $0 | $0 | $0 | 1 |
| MS AMY SCHULMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PAUL L JOSKOW | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
2016 · 28 people listed · 10 paid, $3.0M · 412 employees · 31 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $480,674 | $0 | $0 | $480,674 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $410,810 | $0 | $34,607 | $445,417 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $331,405 | $0 | $36,779 | $368,184 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY)- END 12/2016 | 40 | $329,308 | $0 | $34,563 | $363,871 | 1 |
| DR RICHARD YOUNG | MEMBER (FACULTY) | 40 | $313,502 | $0 | $38,555 | $352,057 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $312,248 | $0 | $37,079 | $349,327 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $294,048 | $0 | $36,779 | $330,827 | 1 |
| MS LAURA SANDER | CFO & TREASURER - END 7/2016 | 40 | $145,247 | $0 | $19,655 | $164,902 | 1 |
| LAURA KETCHUM | CFO - SINCE 9/16 | 40 | $83,494 | $0 | $8,208 | $91,702 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $70,103 | $0 | $7,957 | $78,060 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | $0 | $0 | $0 | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ANDREW LO | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ARTHUR SCHLEIFER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR MICHAEL BONNEY | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| THE HON DEVAL PATRICK | DIRECTOR - SINCE 9/16 | 2 | $0 | $0 | $0 | $0 | 1 |
| MS AMY SCHULMAN | DIRECTOR - SINCE 9/16 | 2 | $0 | $0 | $0 | $0 | 1 |
| MS LILIANA BACHRACH | DIRECTOR - END 09/16 | 2 | $0 | $0 | $0 | $0 | 1 |
2015 · 25 people listed · 9 paid, $2.9M · 439 employees · 31 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $474,350 | $0 | $0 | $474,350 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $400,634 | $0 | $34,463 | $435,097 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $323,152 | $0 | $36,611 | $359,763 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $297,944 | $0 | $37,011 | $334,955 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $284,883 | $0 | $36,611 | $321,494 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY) | 40 | $274,288 | $0 | $36,907 | $311,195 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $270,510 | $0 | $33,916 | $304,426 | 1 |
| MS LAURA SANDER | CFO/TREASURER | 40 | $253,333 | $0 | $31,759 | $285,092 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $68,493 | $0 | $7,649 | $76,142 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | $0 | $0 | $0 | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| Ms Liliana Bachrach | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Andrew Lo | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Arthur Schleifer | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| MR MICHAEL BONNEY | DIRECTOR (SINCE 12/2015) | 2 | $0 | $0 | $0 | $0 | 1 |
2014 · 28 people listed · 9 paid, $2.9M · 449 employees · 31 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $533,600 | $0 | $0 | $533,600 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $391,403 | $0 | $33,658 | $425,061 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $316,842 | $0 | $35,692 | $352,534 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $289,664 | $0 | $36,292 | $325,956 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY) | 40 | $282,930 | $0 | $35,671 | $318,601 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $277,114 | $0 | $35,692 | $312,806 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $274,418 | $0 | $32,601 | $307,019 | 1 |
| MS LAURA SANDER | CFO/TREASURER | 40 | $244,877 | $0 | $33,345 | $278,222 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $66,876 | $0 | $7,428 | $74,304 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | $0 | $0 | $0 | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR LANDON CLAY | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR NANCY ROSE | DIRECTOR (UNTIL 8/31/2014) | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR JOSHUA S BOGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| Ms Liliana Bachrach | Director (SINCE 9/17/2014) | 2 | $0 | $0 | $0 | $0 | 1 |
| Mr Neil Chayet | Director (UNTIL 9/17/2014) | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Andrew Lo | Director (SINCE 3/11/2015) | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Arthur Schleifer | Director (SINCE 9/17/2014) | 2 | $0 | $0 | $0 | $0 | 1 |
2013 · 26 people listed · 9 paid, $2.8M · 461 employees · 31 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $434,555 | - | - | $434,555 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $382,421 | - | $32,890 | $415,311 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $307,152 | - | $34,656 | $341,808 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY) | 40 | $290,647 | - | $34,302 | $324,949 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $281,237 | - | $35,994 | $317,231 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $267,505 | - | $34,656 | $302,161 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $260,341 | - | $30,755 | $291,096 | 1 |
| MS LAURA SANDER | CFO/TREASURER | 40 | $236,465 | - | $35,224 | $271,689 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY | 40 | $65,394 | - | $7,156 | $72,550 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | - | - | - | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | - | - | - | $0 | 2 |
| MR LANDON CLAY | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR PETER KIM | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | - | - | - | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR NANCY ROSE | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | - | - | - | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR NEIL CHAYET | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR JOSHUA S BOGER | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR | 2 | - | - | - | $0 | 1 |
2012 · 28 people listed · 10 paid, $2.7M · 412 employees · 32 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $382,137 | - | - | $382,137 | 1 |
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $332,116 | $0 | $32,148 | $364,264 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $303,026 | - | $33,826 | $336,852 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY) | 40 | $291,971 | - | $33,155 | $325,126 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $275,206 | - | $36,071 | $311,277 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $263,750 | - | $33,826 | $297,576 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $245,059 | - | $28,825 | $273,884 | 1 |
| MS LAURA SANDER | CFO/TREASURER | 40 | $228,797 | - | $34,260 | $263,057 | 1 |
| MS KIMBERLY FORNESS | ASST SECRETARY(UNTIL DEC 2012) | 40 | $64,182 | - | $18,764 | $82,946 | 1 |
| MS CAROLINE ROMANO | ASST SECRETARY(SINCE JAN 2013) | 40 | $50,654 | - | $5,721 | $56,375 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | - | - | - | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | - | - | - | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | - | - | - | $0 | 2 |
| MR LANDON CLAY | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR PETER HECHT | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR PETER KIM | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | - | - | - | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR NANCY ROSE | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | - | - | - | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | - | - | - | $0 | 1 |
| MR NEIL CHAYET | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR JOSHUA S BOGER | DIRECTOR | 2 | - | - | - | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR | 2 | - | - | - | $0 | 1 |
2011 · 27 people listed · 9 paid, $2.6M · 390 employees · 32 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $332,510 | $0 | $31,296 | $363,806 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $296,529 | $0 | $32,585 | $329,114 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $296,611 | $0 | $26,947 | $323,558 | 1 |
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $316,072 | $0 | $0 | $316,072 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY) | 40 | $279,011 | $0 | $31,627 | $310,638 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $266,586 | $0 | $34,424 | $301,010 | 1 |
| DR ROBERT WEINBERG | MEMBER (FACULTY) | 40 | $252,195 | $0 | $32,605 | $284,800 | 1 |
| MS LAURA SANDER | CFO/TREASURER | 40 | $227,366 | $0 | $29,732 | $257,098 | 1 |
| MS KIMBERLY FORNESS | ASSISTANT SECRETARY | 40 | $91,232 | $0 | $13,864 | $105,096 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | $0 | $0 | $0 | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR LANDON CLAY | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PETER HECHT | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PETER KIM | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR NANCY ROSE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR NEIL CHAYET | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR JOSHUA S BOGER | DIRECTOR (SINCE DEC 2011) | 2 | $0 | $0 | $0 | $0 | 1 |
| DR WILLIAM POUNDS | DIRECTOR (SINCE JUNE 2012) | 2 | $0 | $0 | $0 | $0 | 1 |
2010 · 25 people listed · 9 paid, $2.3M · 396 employees · 29 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MR MARTIN MULLINS | VICE PRESIDENT | 40 | $365,766 | $0 | $30,561 | $396,327 | 1 |
| DR GERALD FINK | MEMBER (FACULTY) | 40 | $294,853 | $0 | $31,372 | $326,225 | 1 |
| DR DAVID PAGE | DIRECTOR/PRESIDENT | 10 | $307,144 | $0 | $0 | $307,144 | 1 |
| DR HIDDE PLOEGH | MEMBER (FACULTY) | 40 | $266,433 | $0 | $29,107 | $295,540 | 1 |
| DR RUDOLF JAENISCH | MEMBER (FACULTY) | 40 | $256,846 | $0 | $36,796 | $293,642 | 1 |
| DR HAZEL SIVE | MEMBER (FACULTY) | 40 | $247,722 | $0 | $28,233 | $275,955 | 1 |
| DR TERRY ORR-WEAVER | MEMBER (FACULTY) | 40 | $247,591 | $0 | $25,158 | $272,749 | 1 |
| MS KIMBERLY FORNESS | ASSISTANT SECRETARY | 40 | $87,933 | $0 | $11,853 | $99,786 | 1 |
| MS LAURA SANDER | CFO/TREASURER SINCE OCT 2010 | 40 | $71,966 | $0 | $3,475 | $75,441 | 1 |
| MR ARTHUR BRILL | DIRECTOR/SECRETARY | 2 | $0 | $0 | $0 | $0 | 1 |
| DR CHARLES ELLIS | DIRECTOR/BOARD CHAIR | 5 | $0 | $0 | $0 | $0 | 1 |
| MS SUSAN WHITEHEAD | DIRECTOR/BOARD VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR LANDON CLAY | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MS BRIT D'ARBELOFF | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR JONATHAN GOLDSTEIN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PETER HECHT | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PETER KIM | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR DAVID KOCH | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR ROBERT LANGER | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 3 |
| DR MARK LAPMAN | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 2 |
| MR JOHN WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR PETER WHITEHEAD | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| DR NANCY ROSE | DIRECTOR | 2 | $0 | $0 | $0 | $0 | 1 |
| MR NEIL CHAYET | DIRECTOR SINCE SEPT 2010 | 2 | $0 | $0 | $0 | $0 | 1 |
2009 · 25 people listed · 9 paid, $2.3M · 405 employees · 32 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Mr Martin Mullins | Vice President | 40 | $308,859 | $0 | $29,811 | $338,670 | 1 |
| Dr Gerald Fink | MEMBER (FACULTY) | 40 | $291,127 | $0 | $30,639 | $321,766 | 1 |
| Dr Rudolf Jaenisch | MEMBER (FACULTY) | 40 | $262,319 | $0 | $37,075 | $299,394 | 1 |
| Dr Robert Weinberg | Member (Faculty) | 40 | $244,374 | $0 | $45,995 | $290,369 | 1 |
| Dr Hidde Ploegh | Member (Faculty) | 40 | $248,781 | $0 | $28,962 | $277,743 | 1 |
| Dr Hazel Sive | Member (Faculty) | 40 | $222,270 | $0 | $25,819 | $248,089 | 1 |
| Dr David Page | Director/President | 10 | $247,450 | $0 | $0 | $247,450 | 1 |
| Mr John Travia | Treasurer (Until 2/5/10) | 40 | $154,499 | $0 | $25,556 | $180,055 | 3 |
| Ms Kimberly Forness | Assistant Secretary | 40 | $84,607 | $0 | $12,050 | $96,657 | 1 |
| Mr Arthur Brill | Secretary/Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Charles Ellis | Director/Board Chair | 5 | $0 | $0 | $0 | $0 | 1 |
| Ms Susan Whitehead | Director/Board Vice Chair | 2 | $0 | $0 | $0 | $0 | 2 |
| Mr Landon Clay | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Ms Brit d'Arbeloff | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Mr Jonathan Goldstein | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Peter Hecht | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Barbara Imperiali | Director (Until 9/16/09) | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Peter Kim | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Mr David H Koch | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Dr Robert Langer | Director | 2 | $0 | $0 | $0 | $0 | 3 |
| Dr Mark Lapman | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| DR PHILLIP SHARP | Director | 2 | $0 | $0 | $0 | $0 | 2 |
| Mr John Whitehead | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| Mr Peter Whitehead | Director | 2 | $0 | $0 | $0 | $0 | 1 |
| DR NANCY ROSE | DIRECTOR (AS OF 12/16/09) | 2 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $4.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $2,188,436 |
| SEI BOSTON LLC | CINCINNATI, OH | CONSULTING SERVICES | $762,760 |
| HINCKLEY ALLEN SNYDER LLP | PROVIDENCE, RI | LEGAL | $679,863 |
| NX2 SERVICES LLC | WALTHAM, MA | CLEANING | $654,337 |
| MORSE BARNES-BROWN PENDLETON PC | WALTHAM, MA | LEGAL FIRM | $599,097 |
2023 · 5 contractors · $5.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $2,486,718 |
| SEI BOSTON LLC | CINCINNATI, OH | CONSULTING SERVICES | $959,086 |
| Nx2 SERVICES LLC | WALTHAM, MA | CLEANING | $799,371 |
| MORSE BARNES-BROWN PENDLETON PC | WALTHAM, MA | LEGAL FIRM | $650,302 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | LEGAL | $330,714 |
2022 · 5 contractors · $4.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $2,302,126 |
| MORSE BARNES-BROWN PENDLETON PC | WALTHAM, MA | LEGAL FIRM | $514,237 |
| NX 2 SERVICES LLC | WALTHAM, MA | CLEANING | $496,563 |
| PALLADION SERVICES | BOSTON, MA | SECURITY | $331,438 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | LEGAL | $312,512 |
2021 · 5 contractors · $4.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $2,266,417 |
| HINCKLEY ALLEN SNYDER LLP | BOSTON, MA | LEGAL | $878,466 |
| MORSE BARNES-BROWN PENDLETON PC | WALTHAM, MA | LEGAL FIRM | $701,120 |
| PALLADION SERVICES | BOSTON, MA | SECURITY | $447,591 |
| SALT CREEK CATERING | READING, MA | catering services | $322,018 |
2020 · 5 contractors · $3.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,924,820 |
| JC CANNISTRARO | WATERTOWN, MA | CONSTRUCTION | $546,493 |
| PIDC CONSTRUCTION CORP | MILFORD, MA | construction | $482,018 |
| Salt Creek Catering | READING, MA | catering services | $415,497 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $375,209 |
2019 · 5 contractors · $7.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| PIDC CONSTRUCTION CORP | MILFORD, MA | construction | $4,012,698 |
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,771,607 |
| JC CANNISTRARO | WATERTOWN, MA | CONSTRUCTION | $688,821 |
| Salt Creek Catering | READING, MA | catering services | $507,249 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $450,029 |
2018 · 5 contractors · $13.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| PIDC CONSTRUCTION CORP | MILFORD, MA | construction | $10,443,177 |
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,565,046 |
| Salt Creek Catering | READING, MA | catering services | $495,168 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $450,868 |
| PriceWaterhouseCoopers | BOSTON, MA | ACCOUNTING SERVICES | $272,987 |
2017 · 5 contractors · $11.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| PIDC CONSTRUCTION CORP | MILFORD, MA | construction | $8,040,443 |
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,636,010 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | LEGAL FIRM | $567,793 |
| Salt Creek Catering | READING, MA | catering services | $497,241 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $433,990 |
2016 · 5 contractors · $3.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,470,742 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $567,793 |
| PIDC CONSTRUCTION CORP | CAMBRIDGE, MA | construction | $559,853 |
| Salt Creek Catering | READING, MA | catering services | $464,981 |
| SIENNA CONSTRUCTION CORP | CAMBRIDGE, MA | CONTRACTING SERVICES | $438,506 |
2015 · 5 contractors · $3.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,211,008 |
| SIENNA CONSTRUCTION CORP | CAMBRIDGE, MA | CONTRACTING SERVICES | $887,912 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $475,861 |
| BAIN CAPITAL | BOSTON, MA | INVESTMENT MANAGER | $328,708 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | CONTRACTING SERVICES | $316,819 |
2014 · 5 contractors · $3.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE INVESTMENT FUND FOR FOUNDATIONS | RADNOR, PA | INVESTMENT MANAGER | $1,136,877 |
| SIENNA CONSTRUCTION CORP | CAMBRIDGE, MA | CONTRACTING SERVICES | $1,069,354 |
| JCCANNISTRARO LLC | WATERTOWN, MA | CONTRACTING SERVICES | $685,229 |
| MORSE BARNES-BROWN | WALTHAM, MA | LEGAL FIRM | $505,077 |
| BAIN CAPITAL | BOSTON, MA | INVESTMENT MANAGER | $387,204 |
2013 · 5 contractors · $3.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| SIENNA CONSTRUCTION CORP | CONTRACTING SERVICES | $872,551 | |
| THE INVESTMENT FUND FOR FOUNDATIONS | INVESTMENT MANAGER | $854,399 | |
| CAPITAL GUARDIAN TRUST COMPANY | INVESTMENT MANAGER | $786,625 | |
| BAIN CAPITAL | INVESTMENT MANAGER | $407,889 | |
| MORSE BARNES-BROWN | LEGAL FIRM | $398,259 |
2012 · 5 contractors · $3.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| SIENNA CONSTRUCTION CORP | CAMBRIDGE, MA | CONTRACTING SERVICES | $1,076,433 |
| CAPITAL GUARDIAN TRUST COMPANY | BREA, CA | INVESTMENT MANAGER | $1,031,302 |
| THE INVESTMENT FUND FOR FOUNDATIONS | WEST CONSHOHOCKEN, PA | INVESTMENT MANAGER | $760,782 |
| BAIN CAPITAL | BOSTON, MA | INVESTMENT MANAGER | $427,173 |
| SALT CREEK CATERING | READING, MA | CATERING | $384,884 |
2011 · 5 contractors · $4.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| CAPITAL GUARDIAN TRUST COMPANY | BREA, CA | INVESTMENT MANAGER | $2,107,213 |
| SIENNA CONSTRUCTION CORP | CAMBRIDGE, MA | CONTRACTING SERVICES | $800,921 |
| THE INVESTMENT FUND FOR FOUNDATIONS | WEST CONSHOHOCKEN, PA | INVESTMENT MANAGER | $796,263 |
| WILLIAMS CONNOLLY LLP | WASHINGTON, DC | LEGAL COUNSEL | $643,196 |
| BAIN CAPITAL | BOSTON, MA | INVESTMENT MANAGER | $411,679 |
2010 · 5 contractors · $7.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| WILLIAMS CONNOLLY LLP | WASHINGTON, DC | LEGAL COUNSEL | $3,218,489 |
| CAPITAL GUARDIAN TRUST COMPANY | BREA, CA | INVESTMENT MANAGER | $2,143,107 |
| SIENNA CONSTRUCTION CORP | CAMBRIDGE, MA | CONTRACTING SERVICES | $805,801 |
| THE INVESTMENT FUND FOR FOUNDATIONS | WEST CONSHOHOCKEN, PA | INVESTMENT MANAGER | $629,676 |
| BAIN CAPITAL | BOSTON, MA | INVESTMENT MANAGER | $487,567 |
2009 · 5 contractors · $6.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| WILLIAMS CONNOLLY LLP | WASHINGTON, DC | LEGAL COUNSEL | $3,847,497 |
| CAPITAL GUARDIAN TRUST COMPANY | BREA, CA | INVESTMENT MANAGERS | $1,507,975 |
| THE INVESTMENT FUND FOR FOUNDATIONS | WEST CONSHOHOCKEN, PA | INVESTMENT MANAGERS | $496,285 |
| WOLF GREENFIELD SACKS PC | BOSTON, MA | LEGAL COUNSEL | $459,726 |
| BAIN CAPITAL | BOSTON, MA | INVESTMENT MANAGERS | $436,045 |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 9 grants to organizations · $2.6M
Listed grants add up to $2,557,603; the return's “grants paid” expense line says $3,037,600. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2023 · 10 grants to organizations · $2.4M
2022 · 8 grants to organizations · $2.5M
2021 · 4 grants to organizations · $887K
2020 · 4 grants to organizations · $910K
2019 · 5 grants to organizations · $826K
2018 · 7 grants to organizations · $1.7M
2017 · 7 grants to organizations · $2.2M
2016 · 6 grants to organizations · $2.4M
2015 · 7 grants to organizations · $3.9M
2014 · 5 grants to organizations · $1.9M
2013 · 5 grants to organizations · $1.8M
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $222,267,487 | $174,270,117 | $973,242,315 | $828,669,542 | $30,525,503 | $2,429,262 | $2,048,149 | 368 | 16 |
| 2023 · Form 990 | ||||||||
| $164,876,615 | $145,733,750 | $903,412,304 | $762,926,607 | $36,282,922 | $771,855 | $2,131,958 | 360 | 20 |
| 2022 · Form 990 | ||||||||
| $120,192,597 | $122,899,801 | $842,417,084 | $708,887,599 | $31,297,792 | $1,160,980 | $1,771,226 | 378 | 18 |
| 2021 · Form 990 | ||||||||
| $110,885,074 | $110,235,410 | $806,821,986 | $676,356,621 | $34,538,779 | $1,477,822 | $1,969,640 | 360 | 15 |
| 2020 · Form 990 | ||||||||
| $97,603,749 | $96,726,988 | $896,132,656 | $768,200,561 | $28,386,567 | $1,095,858 | $1,501,950 | 349 | 15 |
| 2019 · Form 990 | ||||||||
| $72,327,232 | $77,087,871 | $712,253,042 | $558,979,542 | $26,310,722 | $2,036,914 | $1,141,773 | 347 | 15 |
| 2018 · Form 990 | ||||||||
| $83,985,006 | $72,969,532 | $650,160,818 | $565,589,994 | $41,491,136 | $2,779,377 | $1,108,370 | 367 | 14 |
| 2017 · Form 990 | ||||||||
| $70,193,474 | $72,071,760 | $627,527,372 | $539,229,106 | $32,935,474 | $1,740,021 | $1,044,798 | 380 | 31 |
| 2016 · Form 990 | ||||||||
| $96,307,678 | $77,179,552 | $609,489,405 | $516,932,974 | $38,473,117 | $2,308,127 | $1,050,243 | 412 | 31 |
| 2015 · Form 990 | ||||||||
| $55,886,798 | $78,487,727 | $570,313,583 | $472,666,786 | $45,139,530 | $1,633,762 | $1,228,919 | 439 | 31 |
| 2014 · Form 990 | ||||||||
| $73,964,154 | $75,854,133 | $572,707,579 | $507,888,936 | $37,140,292 | $1,308,895 | $1,173,570 | 449 | 31 |
| 2013 · Form 990 | ||||||||
| $70,200,667 | $75,477,118 | $577,610,883 | $523,442,215 | $34,141,576 | $1,517,055 | $1,129,461 | 461 | 31 |
| 2012 · Form 990 | ||||||||
| $71,621,169 | $72,838,428 | $529,281,783 | $474,050,448 | $32,908,670 | $647,079 | $1,136,927 | 412 | 32 |
| 2011 · Form 990 | ||||||||
| $64,468,527 | $70,673,639 | $506,336,838 | $446,786,420 | $32,697,910 | $758,303 | $1,043,709 | 390 | 32 |
| 2010 · Form 990 | ||||||||
| $65,829,721 | $69,328,486 | $539,050,931 | $490,378,559 | $33,803,316 | $488,112 | $1,009,603 | 396 | 29 |
| 2009 · Form 990 | ||||||||
| $67,226,653 | $76,732,724 | $477,787,129 | $425,466,960 | $32,834,466 | $451,665 | $902,539 | 405 | 32 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY Cambridge, MA · 3 people in common (Mr Seth Alexander, Ms Susan Whitehead, Sally Kornbluth)
- CHILDRENS HOSPITAL CORPORATION Boston, MA · 2 people in common (Harvey Lodish PhD, Kevin Churchwell MD)
- CHILDRENS MEDICAL CENTER Boston, MA · 2 people in common (Harvey Lodish PhD, Kevin Churchwell MD)
- BROAD INSTITUTE INC Cambridge, MA · 1 person in common (Sally Kornbluth)
- PHYSICIANS ORGANIZATION AT CHILDRENS HOSPITAL INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY WELFARE BENEFIT PLANS T Cambridge, MA · 1 person in common (Mr Seth Alexander)
- BOYS AND GIRLS CLUBS OF BOSTON INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- Immune Disease Institute Inc Boston, MA · 1 person in common (Harvey Lodish PhD)
- BOSTON CHILDRENS NETWORK SPECIALTY PHYSICIANS INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- BOSTON PRIVATE INDUSTRY COUNCIL INC THE Boston, MA · 1 person in common (Kevin Churchwell MD)
- GREATER BOSTON CHAMBER OF COMMERCE Boston, MA · 1 person in common (Kevin Churchwell MD)
- MASSACHUSETTS BUSINESS ROUNDTABLE INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- MIT REAL ESTATE FOUNDATION INC Cambridge, MA · 1 person in common (Mr Seth Alexander)
- DANA-FARBER CHILDRENS HOSPITAL CANCER CARE INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- LONGWOOD RESEARCH INSTITUTE INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- CHB PROPERTIES INC Boston, MA · 1 person in common (Kevin Churchwell MD)
- BLOOD RESEARCH INSTITUTE INC Boston, MA · 1 person in common (Kevin Churchwell MD)
Funders of this organization
111 grantors reported grants to this organization, $83,047,482 in all, tax years 2009 to 2025; the 25 largest shown (all 111). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| GS DONOR ADVISED PHILANTHROPY FUND FOR WEALTH MANAGEMENT INC | $10,902,500 | 8 | $110,000 | 2024 | 2017-2024 | DAF sponsor | Exact | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | $4,738,698 | 9 | $824,000 | 2024 | 2016-2024 | DAF sponsor | Exact | show |
| SILICON VALLEY COMMUNITY FOUNDATION | $3,856,287 | 4 | $916,787 | 2024 | 2020, 2022-2024 | DAF sponsor | Exact | show |
| MILKY WAY RESEARCH FOUNDATION | $3,450,000 | 4 | $1,150,000 | 2024 | 2021-2022, 2024 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| AMERICAN CANCER SOCIETY INC | $3,213,333 | 11 | $37,333 | 2023 | 2009-2011, 2013, 2015-2018, 2021-2023 | Public charity | Exact | show |
| BREAST CANCER RESEARCH FOUNDATION INC | $3,044,250 | 14 | $56,250 | 2024 | 2009, 2011-2013, 2015-2024 | Public charity | Exact | show |
| FREEDOM TOGETHER FOUNDATION | $3,015,890 | 4 | $750,000 | 2016 | 2013-2016 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| GORDON E AND BETTY I MOORE FOUNDATION | $2,869,510 | 5 | $2,038,260 | 2023 | 2018-2019, 2023 | Private foundation | Fuzzy filed as “Whitehead Institute for Biomedical Research”, “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| G HAROLD AND LEILA MATHERS CHARITABLE FOUNDATION | $2,677,040 | 16 | $401,611 | 2024 | 2018-2024 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| BROAD INSTITUTE INC | $2,631,791 | 11 | $1,004,550 | 2024 | 2009, 2011-2013, 2017-2020, 2022-2024 | Public charity | Exact | show |
| GATES FOUNDATION | $2,437,500 | 1 | $2,437,500 | 2023 | 2023 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| VALHALLA FOUNDATION | $2,150,000 | 4 | $400,000 | 2022 | 2019-2022 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION | $1,994,364 | 7 | $230,000 | 2020 | 2014-2020 | Public charity | Exact | show |
| DANA-FARBER CANCER INSTITUTE | $1,836,964 | 3 | $602,587 | 2012 | 2009-2010, 2012 | Public charity | Exact | show |
| ADVANCED MEDICAL RESEARCH FOUNDATION INC | $1,711,900 | 7 | $200,000 | 2022 | 2013-2014, 2017-2019, 2021-2022 | Public charity | Exact | show |
| SUSAN G KOMEN BREAST CANCER FOUNDATION | $1,668,000 | 8 | $12,000 | 2018 | 2010-2013, 2015-2018 | Public charity | Exact | show |
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | $1,664,708 | 7 | $409,113 | 2023 | 2009, 2011-2013, 2021-2023 | DAF sponsor | Exact | show |
| HOWARD HUGHES MEDICAL INSTITUTE | $1,648,377 | 8 | $20,000 | 2024 | 2018-2019, 2021-2024 | Public charity | Exact | show |
| ALZHEIMERS DISEASE RESEARCH FOUNDATION | $1,593,250 | 8 | $307,500 | 2022 | 2016-2022 | Public charity | Exact | show |
| ALLEN FAMILY PHILANTHROPIES | $1,500,000 | 3 | $500,000 | 2023 | 2021-2023 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| JOHN TEMPLETON FOUNDATION | $1,481,295 | 2 | $200,000 | 2024 | 2022, 2024 | Private foundation | Fuzzy filed as “WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH” | show |
| PEW CHARITABLE TRUSTS | $1,415,000 | 10 | $75,000 | 2024 | 2011, 2014, 2017, 2019-2020, 2022-2024 | DAF sponsor | Exact | show |
| BLOOD CANCER UNITED INC | $1,146,749 | 15 | $75,000 | 2017 | 2009-2015, 2017 | Public charity | Exact | show |
| DONOR ADVISED CHARITABLE GIVING | $1,110,050 | 5 | $310,050 | 2024 | 2015, 2021-2024 | DAF sponsor | Exact | show |
| NOVO NORDISK FONDEN | $1,015,155 | 1 | $1,015,155 | 2024 | 2024 | Public charity | Exact | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE | CA | H92 | $114,401,821 | $116,107,616 | CEO & PRESIDENT | $1,345,526 | Same NTEE code H92, revenue within 2x |
| OKLAHOMA MEDICAL RESEARCH FOUNDATION | OK | H92 | $136,776,829 | $126,476,987 | EVP and Chief Medical Officer | $1,016,574 | Same NTEE code H92, revenue within 2x |
| LOVELACE BIOMEDICAL RESEARCH INSTITUTE | NM | H92 | $83,397,041 | $87,744,696 | PRESIDENT AND CHAIRMAN OF THE BOARD | $1,387,128 | Same NTEE code H92, revenue within 5x, similar name |
| STOWERS INSTITUTE FOR MEDICAL RESEARCH | MO | H92 | $102,011,512 | $104,688,153 | DIRECTOR/CHAIR DECEASED 3/27/25 | $3,206,337 | Same NTEE code H92, revenue within 5x, similar name |
| SCRIPPS RESEARCH INSTITUTE | CA | H92 | $698,624,318 | $537,453,981 | PRESIDENT/CEO | $1,859,240 | Same NTEE code H92, revenue within 5x |
| BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | WA | H92 | $81,277,408 | $80,732,627 | CHIEF EXECUTIVE OFFICER VMFH | $5,754,859 | Same NTEE code H92, revenue within 5x |
| FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC | MD | H92 | $78,507,209 | $76,818,918 | Chief Executive Officer | $689,835 | Same NTEE code H92, revenue within 5x |
| GARY AND MARY WEST HEALTH INSTITUTE | CA | H92 | $44,564,569 | $42,453,440 | CMO & EVP CLINICAL RESEARCH | $958,995 | Same NTEE code H92, revenue within 5x |
| JACKSON LABORATORY | ME | H92 | $652,542,607 | $617,013,316 | PRESIDENT & CEO | $2,746,750 | Same NTEE code H92, revenue within 5x |
| SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | WA | H92 | $25,335,790 | $25,203,489 | DIRECTOR | $386,696 | Same NTEE code H92, revenue within 10x, similar name |
| HOWARD HUGHES MEDICAL INSTITUTE | MD | H92 | $2,004,784,057 | $1,178,202,544 | VP & CHIEF INVESTMENT OFFICER | $2,004,966 | Same NTEE code H92, revenue within 10x |
| BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA | LA | H92 | $25,307,433 | $20,561,945 | CEO/PRESIDENT | $814,733 | Same NTEE code H92, revenue within 10x |
| NATIONAL BIOMEDICAL RESEARCH FOUNDATION INC | MA | H92 | $63,494 | $586,889 | PRESIDENT | $0 | Same NTEE code H92, revenue differs more than 10x, same state, similar name |
| SONA GLOBAL LIMITED | MA | H92 | $101,394 | $47,032 | President | $0 | Same NTEE code H92, revenue differs more than 10x, same state |
| BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA | CA | H92 | $141,627 | $136,871 | PRESIDENT AND CEO | $29,482 | Same NTEE code H92, revenue differs more than 10x, similar name |
| FOUNDATION FOR BIOMEDICAL RESEARCH | DC | H92 | $1,931,597 | $1,205,880 | PRESIDENT | $199,375 | Same NTEE code H92, revenue differs more than 10x, similar name |
| GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE | VA | H92 | $494 | $0 | PRESIDENT | $0 | Same NTEE code H92, revenue differs more than 10x |
| BUFFALO INSTITUTE FOR MEDICAL RESEARCH INC | NY | H92 | $991,228 | $887,274 | DIRECTOR | $434,775 | Same NTEE code H92, revenue differs more than 10x, similar name |
| WISCONSIN CORPORATION FOR BIOMEDICAL RESEARCH | WI | H92 | $776,831 | $490,153 | BOARD MEMBER | $352,262 | Same NTEE code H92, revenue differs more than 10x |
| STATES UNITED FOR BIOMEDICAL RESEARCH INC | NC | H92 | $26,200 | $25,415 | PRESIDENT | $0 | Same NTEE code H92, revenue differs more than 10x, similar name |
| APPLIED BIOMEDICAL SCIENCE INSTITUTE | CA | H92 | $4,539,463 | $4,281,826 | PROFESSOR | $223,011 | Same NTEE code H92, revenue differs more than 10x |
| STEADMAN PHILIPPON RESEARCH INSTITUTE | CO | H92 | $14,151,760 | $16,201,121 | CHIEF SCIENTIFIC OFFICER | $661,826 | Same NTEE code H92, revenue differs more than 10x |
| SOUTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION | CA | H92 | $2,941,163 | $2,335,904 | Chair | $419,756 | Same NTEE code H92, revenue differs more than 10x |
| LIFESPAN RESEARCH INSTITUTION | CA | H92 | $1,799,122 | $6,520,518 | Chief Executive Officer | $292,427 | Same NTEE code H92, revenue differs more than 10x |
| PENNINGTON BIOMEDICAL RESEARCH FOUNDATION | LA | H92 | $4,483,977 | $4,163,749 | CHIEF DEVELOPMENT OFFICER | $256,778 | Same NTEE code H92, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $174,270,117 spent · pay $40,884,805 · grants $3,037,600 · events $945,919
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Royalties | $65,865,940 | $65,865,940 | - | - | 37.8% | |
| Other salaries and wages | $27,712,541 | $22,025,215 | $5,000,321 | $687,005 | 15.9% | |
| All other expenses | $15,402,179 | $14,767,991 | $607,680 | $26,508 | 8.8% | |
| Other (as described) | LAB SUPPLIES | $10,289,829 | $10,283,575 | $6,254 | - | 5.9% |
| Other employee benefits | $6,383,936 | $4,383,949 | $1,814,196 | $185,791 | 3.7% | |
| Depreciation and depletion | $5,693,775 | $5,010,839 | $682,936 | - | 3.3% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $5,428,372 | $3,633,885 | $1,760,227 | $34,260 | 3.1% |
| Other (as described) | FELLOWSHIPS | $5,023,420 | $4,965,102 | $58,318 | - | 2.9% |
| Fees: other services | $3,757,260 | $1,716,360 | $1,647,180 | $393,720 | 2.2% | |
| Interest | $3,662,499 | $3,214,575 | $447,924 | - | 2.1% | |
| Other (as described) | OTHER LAB EXPENSES | $3,529,283 | $3,529,283 | - | - | 2.0% |
| Pension plan contributions | $2,572,774 | $1,931,456 | $554,651 | $86,667 | 1.5% | |
| Fees: investment management | $2,565,753 | $136,213 | $2,429,540 | - | 1.5% | |
| Occupancy | $2,560,240 | $2,233,046 | $327,194 | - | 1.5% | |
| Grants to US organizations and governments | $2,557,603 | $2,557,603 | - | - | 1.5% | |
| Pay: officers, directors, trustees, key employees | $2,048,149 | $414,480 | $1,313,773 | $319,896 | 1.2% | |
| Payroll taxes | $2,037,553 | $1,529,650 | $439,265 | $68,638 | 1.2% | |
| Information technology | $1,854,317 | $67,161 | $1,759,593 | $27,563 | 1.1% | |
| Fees: legal | $1,355,110 | $1,189,805 | $152,280 | $13,025 | 0.8% | |
| Office expenses | $1,077,326 | $789,434 | $268,094 | $19,798 | 0.6% | |
| Conferences, conventions and meetings | $945,919 | $595,034 | $239,988 | $110,897 | 0.5% | |
| Grants outside the US | $479,997 | $479,997 | - | - | 0.3% | |
| Travel | $470,737 | $370,870 | $77,735 | $22,132 | 0.3% | |
| Fees: accounting | $456,160 | - | $456,160 | - | 0.3% | |
| Insurance | $406,605 | $377,284 | $29,321 | - | 0.2% | |
| Pay: disqualified persons | $129,852 | - | $129,852 | - | 0.1% | |
| Advertising and promotion | $2,988 | $1,508 | - | $1,480 | 0.0% | |
| Total | $174,270,117 | 100% |
2023 · Form 990 · $145,733,753 spent · pay $39,388,274 · grants $2,402,028 · events $889,466
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Royalties | $46,016,881 | $46,016,881 | - | - | 31.6% | |
| Other salaries and wages | $26,150,556 | $20,616,394 | $5,020,255 | $513,907 | 17.9% | |
| Other (as described) | LAB SUPPLIES | $10,656,084 | $10,650,287 | $5,797 | - | 7.3% |
| All other expenses | $9,600,934 | $9,346,286 | $230,018 | $24,630 | 6.6% | |
| Other employee benefits | $6,569,856 | $4,094,195 | $2,292,221 | $183,440 | 4.5% | |
| Depreciation and depletion | $5,454,112 | $4,742,496 | $711,616 | - | 3.7% | |
| Other (as described) | FELLOWSHIPS | $4,764,876 | $4,629,792 | $135,084 | - | 3.3% |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $4,434,633 | $3,178,302 | $1,215,726 | $40,605 | 3.0% |
| Fees: other services | $3,890,044 | $1,616,294 | $2,092,806 | $180,945 | 2.7% | |
| Interest | $3,659,813 | $3,212,218 | $447,595 | - | 2.5% | |
| Other (as described) | OTHER LAB EXPENSES | $3,026,191 | $3,026,191 | - | - | 2.1% |
| Fees: investment management | $2,842,825 | $151,869 | $2,690,956 | - | 2.0% | |
| Occupancy | $2,607,928 | $2,193,164 | $414,764 | - | 1.8% | |
| Pension plan contributions | $2,473,125 | $1,829,803 | $556,055 | $87,267 | 1.7% | |
| Grants to US organizations and governments | $2,402,028 | $2,402,028 | - | - | 1.6% | |
| Pay: officers, directors, trustees, key employees | $2,131,958 | $402,408 | $1,241,031 | $488,519 | 1.5% | |
| Information technology | $2,043,532 | $26,789 | $2,016,743 | - | 1.4% | |
| Payroll taxes | $1,936,709 | $1,434,175 | $434,365 | $68,169 | 1.3% | |
| Fees: legal | $1,809,252 | $1,627,017 | $176,386 | $5,849 | 1.2% | |
| Office expenses | $985,465 | $708,401 | $262,935 | $14,129 | 0.7% | |
| Conferences, conventions and meetings | $889,466 | $576,706 | $261,145 | $51,615 | 0.6% | |
| Travel | $507,551 | $403,292 | $102,319 | $1,940 | 0.3% | |
| Insurance | $415,899 | $365,127 | $50,772 | - | 0.3% | |
| Fees: accounting | $337,115 | - | $337,115 | - | 0.2% | |
| Pay: disqualified persons | $126,070 | - | $126,070 | - | 0.1% | |
| Advertising and promotion | $847 | $36 | $11 | $800 | 0.0% | |
| Total | $145,733,753 | 100% |
2022 · Form 990 · $122,899,801 spent · pay $35,497,079 · grants $2,481,689 · events $619,820
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Royalties | $30,523,178 | $30,523,178 | - | - | 24.8% | |
| Other salaries and wages | $23,856,187 | $19,707,260 | $3,653,523 | $495,404 | 19.4% | |
| Other (as described) | LAB SUPPLIES | $10,430,934 | $10,416,148 | $14,786 | - | 8.5% |
| All other expenses | $8,010,129 | $7,175,233 | $814,378 | $20,518 | 6.5% | |
| Depreciation and depletion | $5,924,267 | $5,112,050 | $812,217 | - | 4.8% | |
| Other employee benefits | $5,895,972 | $4,325,314 | $1,397,080 | $173,578 | 4.8% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $5,147,903 | $3,219,640 | $1,896,203 | $32,060 | 4.2% |
| Other (as described) | FELLOWSHIPS | $4,662,380 | $4,662,380 | - | - | 3.8% |
| Interest | $3,639,848 | $3,140,825 | $499,023 | - | 3.0% | |
| Fees: other services | $3,635,744 | $1,198,407 | $2,222,110 | $215,227 | 3.0% | |
| Other (as described) | OTHER LAB EXPENSES | $3,345,526 | $3,345,526 | - | - | 2.7% |
| Fees: investment management | $2,671,903 | - | $2,671,903 | - | 2.2% | |
| Grants to US organizations and governments | $2,481,689 | $2,481,689 | - | - | 2.0% | |
| Occupancy | $2,422,045 | $2,100,640 | $321,405 | - | 2.0% | |
| Pension plan contributions | $2,284,128 | $1,791,296 | $410,952 | $81,880 | 1.9% | |
| Pay: officers, directors, trustees, key employees | $1,771,226 | $390,687 | $997,064 | $383,475 | 1.4% | |
| Payroll taxes | $1,689,566 | $1,325,019 | $303,981 | $60,566 | 1.4% | |
| Fees: legal | $1,340,431 | $1,264,737 | $62,918 | $12,776 | 1.1% | |
| Information technology | $1,103,026 | $253,367 | $847,398 | $2,261 | 0.9% | |
| Conferences, conventions and meetings | $619,820 | $379,510 | $173,314 | $66,996 | 0.5% | |
| Fees: accounting | $393,942 | - | $393,942 | - | 0.3% | |
| Travel | $384,682 | $304,900 | $69,303 | $10,479 | 0.3% | |
| Insurance | $330,573 | $239,849 | $90,724 | - | 0.3% | |
| Office expenses | $301,554 | $215,646 | $63,587 | $22,321 | 0.2% | |
| Advertising and promotion | $33,148 | $15,869 | $3,719 | $13,560 | 0.0% | |
| Total | $122,899,801 | 100% |
2021 · Form 990 · $110,235,410 spent · pay $34,031,432 · grants $886,824 · events $264,331
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Royalties | $23,757,222 | $23,757,222 | - | - | 21.6% | |
| Other salaries and wages | $22,912,758 | $18,366,335 | $4,112,818 | $433,605 | 20.8% | |
| Other (as described) | LAB SUPPLIES | $10,060,064 | $9,947,773 | $112,291 | - | 9.1% |
| All other expenses | $7,014,241 | $5,998,297 | $1,002,083 | $13,861 | 6.4% | |
| Depreciation and depletion | $6,086,573 | $5,252,104 | $834,469 | - | 5.5% | |
| Other employee benefits | $5,256,082 | $4,109,125 | $973,249 | $173,708 | 4.8% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $5,023,056 | $3,464,957 | $1,521,572 | $36,527 | 4.6% |
| Other (as described) | FELLOWSHIPS | $4,372,137 | $4,372,137 | - | - | 4.0% |
| Interest | $3,728,094 | $3,216,972 | $511,122 | - | 3.4% | |
| Other (as described) | OTHER LAB EXPENSES | $2,997,489 | $2,997,489 | - | - | 2.7% |
| Fees: other services | $2,741,163 | $960,221 | $1,677,396 | $103,546 | 2.5% | |
| Fees: investment management | $2,562,376 | - | $2,562,376 | - | 2.3% | |
| Occupancy | $2,298,368 | $1,993,375 | $304,993 | - | 2.1% | |
| Pension plan contributions | $2,258,095 | $1,717,292 | $460,187 | $80,616 | 2.0% | |
| Fees: legal | $2,229,779 | $1,829,203 | $392,918 | $7,658 | 2.0% | |
| Pay: officers, directors, trustees, key employees | $1,969,640 | $376,835 | $1,138,085 | $454,720 | 1.8% | |
| Payroll taxes | $1,634,857 | $1,243,316 | $333,175 | $58,366 | 1.5% | |
| Information technology | $1,107,478 | $291,843 | $804,358 | $11,277 | 1.0% | |
| Grants to US organizations and governments | $886,824 | $886,824 | - | - | 0.8% | |
| Office expenses | $281,042 | $217,858 | $46,137 | $17,047 | 0.3% | |
| Fees: accounting | $271,335 | - | $271,335 | - | 0.2% | |
| Conferences, conventions and meetings | $264,331 | $181,597 | $80,460 | $2,274 | 0.2% | |
| Insurance | $261,279 | $226,607 | $34,672 | - | 0.2% | |
| Travel | $205,174 | $129,101 | $69,733 | $6,340 | 0.2% | |
| Advertising and promotion | $55,953 | $19,186 | $20,647 | $16,120 | 0.1% | |
| Total | $110,235,410 | 100% |
2020 · Form 990 · $96,726,988 spent · pay $32,146,863 · grants $909,821 · events $46,142
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,855,666 | $16,970,872 | $3,967,025 | $917,769 | 22.6% | |
| Royalties | $18,749,254 | $18,749,254 | - | - | 19.4% | |
| Other (as described) | LAB SUPPLIES | $9,277,251 | $9,200,470 | $76,781 | - | 9.6% |
| Depreciation and depletion | $5,721,975 | $4,937,492 | $784,483 | - | 5.9% | |
| Other employee benefits | $5,105,015 | $3,691,308 | $1,235,414 | $178,293 | 5.3% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $4,891,168 | $3,191,317 | $1,682,295 | $17,556 | 5.1% |
| All other expenses | $3,939,343 | $3,082,159 | $835,011 | $22,173 | 4.1% | |
| Interest | $3,668,813 | $3,165,819 | $502,994 | - | 3.8% | |
| Fees: other services | $3,647,036 | $935,735 | $2,606,730 | $104,571 | 3.8% | |
| Other (as described) | FELLOWSHIPS | $3,568,882 | $3,568,882 | - | - | 3.7% |
| Other (as described) | OTHER LAB EXPENSES | $2,630,178 | $2,630,178 | - | - | 2.7% |
| Fees: investment management | $2,130,885 | - | $2,130,885 | - | 2.2% | |
| Pension plan contributions | $2,118,045 | $1,571,773 | $463,050 | $83,222 | 2.2% | |
| Occupancy | $2,036,907 | $1,747,235 | $289,672 | - | 2.1% | |
| Payroll taxes | $1,566,187 | $1,162,246 | $342,402 | $61,539 | 1.6% | |
| Pay: officers, directors, trustees, key employees | $1,501,950 | $362,500 | $1,139,450 | - | 1.6% | |
| Fees: legal | $1,279,742 | $1,217,537 | $62,205 | - | 1.3% | |
| Information technology | $1,031,937 | $269,831 | $753,335 | $8,771 | 1.1% | |
| Grants to US organizations and governments | $909,821 | $909,821 | - | - | 0.9% | |
| Insurance | $386,278 | $333,303 | $52,975 | - | 0.4% | |
| Fees: accounting | $314,684 | - | $314,684 | - | 0.3% | |
| Office expenses | $295,638 | $210,098 | $71,176 | $14,364 | 0.3% | |
| Conferences, conventions and meetings | $46,142 | $40,533 | $5,609 | - | 0.0% | |
| Travel | $31,331 | $13,024 | $18,307 | - | 0.0% | |
| Advertising and promotion | $22,860 | $18,562 | $4,298 | - | 0.0% | |
| Total | $96,726,988 | 100% |
2019 · Form 990 · $77,087,871 spent · pay $30,499,972 · grants $825,846 · events $269,765
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,760,565 | $15,968,960 | $3,864,084 | $927,521 | 26.9% | |
| Royalties | $8,055,999 | $8,055,999 | - | - | 10.5% | |
| Other (as described) | LAB SUPPLIES | $6,506,972 | $6,494,895 | $12,077 | - | 8.4% |
| Depreciation and depletion | $5,774,742 | $4,868,119 | $906,623 | - | 7.5% | |
| Other employee benefits | $5,217,578 | $3,859,189 | $1,166,693 | $191,696 | 6.8% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $4,004,888 | $2,686,600 | $1,285,903 | $32,385 | 5.2% |
| Interest | $3,811,052 | $3,407,163 | $403,889 | - | 4.9% | |
| Other (as described) | FELLOWSHIPS | $2,846,211 | $2,846,211 | - | - | 3.7% |
| Other (as described) | OTHER LAB EXPENSES | $2,564,854 | $2,566,486 | -$1,632 | - | 3.3% |
| All other expenses | $2,409,185 | $1,648,309 | $705,547 | $55,329 | 3.1% | |
| Occupancy | $2,100,835 | $1,755,048 | $345,787 | - | 2.7% | |
| Fees: investment management | $1,963,047 | - | $1,963,047 | - | 2.5% | |
| Pension plan contributions | $1,932,609 | $1,423,083 | $427,684 | $81,842 | 2.5% | |
| Fees: other services | $1,881,875 | $1,079,753 | $690,729 | $111,393 | 2.4% | |
| Payroll taxes | $1,447,447 | $1,065,832 | $320,318 | $61,297 | 1.9% | |
| Fees: legal | $1,301,522 | $1,216,834 | $84,688 | - | 1.7% | |
| Pay: officers, directors, trustees, key employees | $1,141,773 | $158,900 | $982,873 | - | 1.5% | |
| Information technology | $964,323 | $229,259 | $725,277 | $9,787 | 1.3% | |
| Grants to US organizations and governments | $825,846 | $825,846 | - | - | 1.1% | |
| Fees: accounting | $377,385 | - | $377,385 | - | 0.5% | |
| Office expenses | $345,896 | $229,722 | $96,649 | $19,525 | 0.4% | |
| Travel | $298,819 | $210,588 | $59,561 | $28,670 | 0.4% | |
| Conferences, conventions and meetings | $269,765 | $147,798 | $85,592 | $36,375 | 0.3% | |
| Insurance | $267,695 | $225,667 | $42,028 | - | 0.3% | |
| Advertising and promotion | $16,988 | $13,658 | $3,205 | $125 | 0.0% | |
| Total | $77,087,871 | 100% |
2018 · Form 990 · $72,969,532 spent · pay $29,363,753 · grants $1,666,208 · events $496,920
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,229,769 | $15,561,673 | $3,637,703 | $1,030,393 | 27.7% | |
| Other (as described) | LAB SUPPLIES | $8,190,169 | $8,189,533 | $636 | - | 11.2% |
| Royalties | $4,835,352 | $4,835,352 | - | - | 6.6% | |
| Depreciation and depletion | $4,730,970 | $4,111,694 | $619,276 | - | 6.5% | |
| Other employee benefits | $4,718,459 | $3,639,658 | $872,710 | $206,091 | 6.5% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $3,938,693 | $2,992,777 | $921,754 | $24,162 | 5.4% |
| Interest | $3,091,280 | $2,763,671 | $327,609 | - | 4.2% | |
| Other (as described) | FELLOWSHIPS | $3,005,697 | $3,005,697 | - | - | 4.1% |
| Other (as described) | OTHER LAB EXPENSES | $2,632,873 | $2,636,451 | -$3,578 | - | 3.6% |
| Occupancy | $2,449,606 | $2,128,957 | $320,649 | - | 3.4% | |
| Pension plan contributions | $1,879,207 | $1,384,072 | $404,390 | $90,745 | 2.6% | |
| Fees: investment management | $1,859,554 | - | $1,859,554 | - | 2.5% | |
| All other expenses | $1,846,200 | $1,162,266 | $650,989 | $32,945 | 2.5% | |
| Fees: other services | $1,765,748 | $1,081,035 | $610,468 | $74,245 | 2.4% | |
| Grants to US organizations and governments | $1,666,208 | $1,666,208 | - | - | 2.3% | |
| Payroll taxes | $1,427,948 | $1,051,711 | $307,283 | $68,954 | 2.0% | |
| Pay: officers, directors, trustees, key employees | $1,108,370 | $154,272 | $954,098 | - | 1.5% | |
| Fees: legal | $949,667 | $869,375 | $79,237 | $1,055 | 1.3% | |
| Information technology | $837,856 | $273,016 | $561,476 | $3,364 | 1.1% | |
| Conferences, conventions and meetings | $496,920 | $309,181 | $142,571 | $45,168 | 0.7% | |
| Office expenses | $408,623 | $261,685 | $128,152 | $18,786 | 0.6% | |
| Travel | $346,190 | $256,220 | $54,208 | $35,762 | 0.5% | |
| Insurance | $287,458 | $249,830 | $37,628 | - | 0.4% | |
| Fees: accounting | $251,881 | - | $251,881 | - | 0.3% | |
| Advertising and promotion | $14,834 | $11,483 | $3,101 | $250 | 0.0% | |
| Total | $72,969,532 | 100% |
2017 · Form 990 · $72,071,760 spent · pay $29,355,992 · grants $2,154,657 · events $477,639
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,535,485 | $15,938,086 | $3,575,420 | $1,021,979 | 28.5% | |
| Other (as described) | LAB SUPPLIES | $7,735,125 | $7,735,125 | - | - | 10.7% |
| Depreciation and depletion | $4,696,047 | $4,059,000 | $637,047 | - | 6.5% | |
| Other employee benefits | $4,295,215 | $3,389,806 | $718,674 | $186,735 | 6.0% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $4,085,683 | $2,749,166 | $1,291,655 | $44,862 | 5.7% |
| Royalties | $3,756,949 | $3,756,949 | - | - | 5.2% | |
| All other expenses | $3,248,331 | $2,630,194 | $595,074 | $23,063 | 4.5% | |
| Other (as described) | FELLOWSHIPS | $3,167,492 | $3,167,492 | - | - | 4.4% |
| Interest | $3,095,159 | $2,767,139 | $328,020 | - | 4.3% | |
| Occupancy | $2,481,346 | $2,156,542 | $324,804 | - | 3.4% | |
| Grants to US organizations and governments | $2,154,657 | $2,154,657 | - | - | 3.0% | |
| Fees: investment management | $1,918,068 | - | $1,918,068 | - | 2.7% | |
| Pension plan contributions | $1,906,500 | $1,421,275 | $394,939 | $90,286 | 2.6% | |
| Payroll taxes | $1,573,994 | $1,173,395 | $326,059 | $74,540 | 2.2% | |
| Fees: other services | $1,364,946 | $777,038 | $455,286 | $132,622 | 1.9% | |
| Other (as described) | OTHER LAB EXPENSES | $1,111,050 | $1,098,830 | $12,221 | - | 1.5% |
| Fees: legal | $1,093,364 | $959,306 | $127,408 | $6,650 | 1.5% | |
| Pay: officers, directors, trustees, key employees | $1,044,798 | $149,778 | $895,020 | - | 1.4% | |
| Information technology | $873,259 | $224,881 | $641,875 | $6,503 | 1.2% | |
| Office expenses | $518,920 | $303,116 | $170,379 | $45,425 | 0.7% | |
| Conferences, conventions and meetings | $477,639 | $284,199 | $128,438 | $65,002 | 0.7% | |
| Travel | $375,134 | $269,202 | $74,374 | $31,558 | 0.5% | |
| Fees: accounting | $282,073 | - | $282,073 | - | 0.4% | |
| Insurance | $274,520 | $238,586 | $35,934 | - | 0.4% | |
| Advertising and promotion | $6,005 | $4,804 | $1,201 | - | 0.0% | |
| Total | $72,071,760 | 100% |
2016 · Form 990 · $77,179,552 spent · pay $31,651,161 · grants $2,391,442 · events $485,674
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,937,726 | $17,694,780 | $3,527,421 | $715,525 | 28.4% | |
| Other (as described) | LAB SUPPLIES | $9,304,508 | $9,304,508 | - | - | 12.1% |
| Other employee benefits | $5,113,174 | $4,042,036 | $924,212 | $146,926 | 6.6% | |
| Depreciation and depletion | $5,057,653 | $3,998,758 | $1,058,895 | - | 6.6% | |
| Other (as described) | FELLOWSHIPS | $3,855,286 | $3,855,286 | - | - | 5.0% |
| Interest | $3,601,082 | $3,072,895 | $528,187 | - | 4.7% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $3,431,305 | $2,177,023 | $1,224,354 | $29,928 | 4.4% |
| Royalties | $3,176,146 | $3,176,146 | - | - | 4.1% | |
| Other (as described) | OTHER LAB EXPENSES | $3,149,461 | $2,074,862 | $1,043,952 | $30,647 | 4.1% |
| Occupancy | $2,644,686 | $2,587,919 | $56,767 | - | 3.4% | |
| Grants to US organizations and governments | $2,391,442 | $2,391,442 | - | - | 3.1% | |
| All other expenses | $2,183,375 | $2,171,603 | $11,505 | $267 | 2.8% | |
| Pension plan contributions | $1,985,351 | $1,603,757 | $319,706 | $61,888 | 2.6% | |
| Fees: investment management | $1,801,421 | - | $1,801,421 | - | 2.3% | |
| Payroll taxes | $1,564,667 | $1,263,930 | $251,962 | $48,775 | 2.0% | |
| Fees: legal | $1,066,212 | $951,709 | $114,503 | - | 1.4% | |
| Fees: other services | $1,054,425 | $625,941 | $191,311 | $237,173 | 1.4% | |
| Pay: officers, directors, trustees, key employees | $1,050,243 | $145,416 | $904,827 | - | 1.4% | |
| Information technology | $897,505 | $221,491 | $658,593 | $17,421 | 1.2% | |
| Conferences, conventions and meetings | $485,674 | $278,065 | $138,166 | $69,443 | 0.6% | |
| Office expenses | $453,715 | $299,068 | $109,251 | $45,396 | 0.6% | |
| Travel | $407,023 | $268,216 | $78,310 | $60,497 | 0.5% | |
| Fees: accounting | $296,132 | - | $296,132 | - | 0.4% | |
| Insurance | $260,841 | - | $260,841 | - | 0.3% | |
| Advertising and promotion | $10,499 | $8,399 | $2,100 | - | 0.0% | |
| Total | $77,179,552 | 100% |
2015 · Form 990 · $78,487,727 spent · pay $32,174,925 · grants $3,853,503 · events $425,631
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,708,424 | $17,943,064 | $3,226,259 | $539,101 | 27.7% | |
| Other (as described) | LAB SUPPLIES | $10,037,859 | $10,037,859 | - | - | 12.8% |
| Other employee benefits | $5,662,473 | $3,976,234 | $1,498,632 | $187,607 | 7.2% | |
| Depreciation and depletion | $5,113,483 | $4,170,359 | $943,124 | - | 6.5% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $4,240,960 | $2,889,508 | $1,315,799 | $35,653 | 5.4% |
| Grants to US organizations and governments | $3,853,503 | $3,853,503 | - | - | 4.9% | |
| Other (as described) | FELLOWSHIPS | $3,836,332 | $3,836,332 | - | - | 4.9% |
| Interest | $3,265,722 | $2,786,724 | $478,998 | - | 4.2% | |
| Royalties | $2,967,991 | $2,967,991 | - | - | 3.8% | |
| All other expenses | $2,621,682 | $1,972,781 | $618,936 | $29,965 | 3.3% | |
| Occupancy | $2,288,582 | $2,044,488 | $244,094 | - | 2.9% | |
| Pension plan contributions | $2,001,970 | $1,654,725 | $297,529 | $49,716 | 2.6% | |
| Fees: investment management | $1,688,402 | - | $1,688,402 | - | 2.2% | |
| Other (as described) | OTHER LAB EXPENSES | $1,652,446 | $1,652,446 | - | - | 2.1% |
| Fees: legal | $1,612,644 | $1,162,223 | $450,421 | - | 2.1% | |
| Payroll taxes | $1,573,139 | $1,300,276 | $233,796 | $39,067 | 2.0% | |
| Pay: officers, directors, trustees, key employees | $1,228,919 | $212,189 | $1,016,730 | - | 1.6% | |
| Information technology | $807,003 | $212,442 | $582,551 | $12,010 | 1.0% | |
| Fees: other services | $610,982 | $377,159 | $217,354 | $16,469 | 0.8% | |
| Office expenses | $433,553 | $287,416 | $124,497 | $21,640 | 0.6% | |
| Conferences, conventions and meetings | $425,631 | $254,611 | $81,408 | $89,612 | 0.5% | |
| Travel | $384,646 | $292,765 | $61,774 | $30,107 | 0.5% | |
| Fees: accounting | $235,957 | - | $235,957 | - | 0.3% | |
| Insurance | $222,843 | - | $222,843 | - | 0.3% | |
| Advertising and promotion | $12,581 | $8,785 | $3,796 | - | 0.0% | |
| Total | $78,487,727 | 100% |
2014 · Form 990 · $75,854,133 spent · pay $33,354,143 · grants $1,860,335 · events $430,850
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $22,518,390 | $19,324,884 | $2,578,822 | $614,684 | 29.7% | |
| Other (as described) | LAB SUPPLIES | $10,357,045 | $10,357,045 | - | - | 13.7% |
| Depreciation and depletion | $6,693,585 | $4,526,003 | $2,167,582 | - | 8.8% | |
| Other employee benefits | $6,001,026 | $4,752,568 | $1,130,151 | $118,307 | 7.9% | |
| Other (as described) | FELLOWSHIPS | $3,769,234 | $3,753,274 | $15,960 | - | 5.0% |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $3,355,374 | $2,662,172 | $667,286 | $25,916 | 4.4% |
| Royalties | $2,450,198 | $2,450,198 | - | - | 3.2% | |
| Occupancy | $2,326,954 | $1,948,159 | $378,795 | - | 3.1% | |
| All other expenses | $2,273,408 | $1,753,786 | $429,203 | $90,419 | 3.0% | |
| Interest | $2,056,206 | $1,754,613 | $301,593 | - | 2.7% | |
| Pension plan contributions | $2,050,155 | $1,689,544 | $307,420 | $53,191 | 2.7% | |
| Grants to US organizations and governments | $1,860,335 | $1,860,335 | - | - | 2.5% | |
| Other (as described) | OTHER LAB EXPENSES | $1,772,083 | $1,772,083 | - | - | 2.3% |
| Fees: investment management | $1,705,542 | - | $1,705,542 | - | 2.2% | |
| Payroll taxes | $1,611,002 | $1,327,636 | $241,569 | $41,797 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $1,173,570 | $199,788 | $973,782 | - | 1.5% | |
| Information technology | $808,899 | $547,962 | $254,179 | $6,758 | 1.1% | |
| Fees: other services | $707,722 | $257,438 | $426,237 | $24,047 | 0.9% | |
| Fees: legal | $562,009 | $354,403 | $207,606 | - | 0.7% | |
| Office expenses | $490,944 | $389,587 | $86,088 | $15,269 | 0.6% | |
| Conferences, conventions and meetings | $430,850 | $288,743 | $140,798 | $1,309 | 0.6% | |
| Travel | $357,602 | $262,121 | $56,128 | $39,353 | 0.5% | |
| Insurance | $258,561 | - | $258,561 | - | 0.3% | |
| Fees: accounting | $254,972 | - | $254,972 | - | 0.3% | |
| Advertising and promotion | $8,467 | $6,534 | $1,933 | - | 0.0% | |
| Total | $75,854,133 | 100% |
2013 · Form 990 · $75,477,118 spent · pay $32,599,717 · grants $1,828,557 · events $211,650
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $22,126,518 | $19,358,285 | $2,271,527 | $496,706 | 29.3% | |
| Other (as described) | LAB SUPPLIES | $10,713,637 | $10,713,637 | - | - | 14.2% |
| Depreciation and depletion | $8,049,023 | $4,431,654 | $3,617,369 | - | 10.7% | |
| Other employee benefits | $5,749,100 | $4,265,551 | $1,388,947 | $94,602 | 7.6% | |
| Occupancy | $3,818,596 | $3,138,063 | $680,533 | - | 5.1% | |
| Other (as described) | FELLOWSHIPS | $3,152,827 | $3,102,708 | $50,119 | - | 4.2% |
| Royalties | $2,480,707 | $2,480,707 | - | - | 3.3% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $2,293,913 | $1,893,705 | $379,327 | $20,881 | 3.0% |
| Pension plan contributions | $2,020,884 | $1,698,584 | $279,138 | $43,162 | 2.7% | |
| Interest | $1,927,473 | $1,619,916 | $307,557 | - | 2.6% | |
| Other (as described) | OTHER LAB EXPENSES | $1,848,787 | $1,848,787 | - | - | 2.4% |
| Grants to US organizations and governments | $1,828,557 | $1,828,557 | - | - | 2.4% | |
| Payroll taxes | $1,573,754 | $1,322,764 | $217,377 | $33,613 | 2.1% | |
| Fees: investment management | $1,567,716 | - | $1,567,716 | - | 2.1% | |
| All other expenses | $1,424,547 | $846,966 | $504,473 | $73,108 | 1.9% | |
| Pay: officers, directors, trustees, key employees | $1,129,461 | $188,721 | $940,740 | - | 1.5% | |
| Fees: other services | $834,918 | $333,251 | $472,239 | $29,428 | 1.1% | |
| Information technology | $833,583 | $646,016 | $182,168 | $5,399 | 1.1% | |
| Office expenses | $565,494 | $431,813 | $99,095 | $34,586 | 0.7% | |
| Travel | $484,386 | $357,553 | $103,283 | $23,550 | 0.6% | |
| Fees: legal | $413,360 | $256,956 | $156,404 | - | 0.5% | |
| Fees: accounting | $238,390 | - | $238,390 | - | 0.3% | |
| Conferences, conventions and meetings | $211,650 | $184,628 | $25,480 | $1,542 | 0.3% | |
| Insurance | $183,642 | - | $183,642 | - | 0.2% | |
| Advertising and promotion | $6,195 | $5,018 | $1,177 | - | 0.0% | |
| Total | $75,477,118 | 100% |
2012 · Form 990 · $72,838,428 spent · pay $31,775,657 · grants $0 · events $173,459
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,530,453 | $18,421,438 | $2,479,867 | $629,148 | 29.6% | |
| Other (as described) | LAB SUPPLIES | $9,559,001 | $9,559,001 | - | - | 13.1% |
| Depreciation and depletion | $8,041,001 | $4,345,700 | $3,695,301 | - | 11.0% | |
| Other employee benefits | $5,638,974 | $4,669,764 | $842,207 | $127,003 | 7.7% | |
| Occupancy | $3,640,545 | $3,058,021 | $582,524 | - | 5.0% | |
| Other (as described) | FELLOWSHIPS | $3,168,535 | $3,119,609 | $48,926 | - | 4.4% |
| All other expenses | $2,886,602 | $2,258,992 | $556,335 | $71,275 | 4.0% | |
| Fees: investment management | $2,424,868 | - | $2,424,868 | - | 3.3% | |
| Other (as described) | RESEARCH SUBCONTRACTS | $2,307,949 | $2,307,949 | - | - | 3.2% |
| Interest | $1,998,634 | $1,679,723 | $318,911 | - | 2.7% | |
| Pension plan contributions | $1,940,244 | $1,660,072 | $223,476 | $56,696 | 2.7% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $1,902,822 | $1,373,391 | $520,692 | $8,739 | 2.6% |
| Royalties | $1,718,644 | $1,718,644 | - | - | 2.4% | |
| Payroll taxes | $1,529,059 | $1,308,261 | $176,116 | $44,682 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $1,136,927 | $196,134 | $940,793 | - | 1.6% | |
| Fees: legal | $762,320 | $551,154 | $211,166 | - | 1.0% | |
| Information technology | $708,206 | $502,908 | $197,761 | $7,537 | 1.0% | |
| Office expenses | $547,498 | $409,950 | $101,398 | $36,150 | 0.8% | |
| Travel | $381,922 | $283,705 | $62,684 | $35,533 | 0.5% | |
| Fees: accounting | $335,095 | - | $335,095 | - | 0.5% | |
| Fees: other services | $314,243 | $140,477 | $138,936 | $34,830 | 0.4% | |
| Insurance | $189,545 | - | $189,545 | - | 0.3% | |
| Conferences, conventions and meetings | $173,459 | $144,759 | $22,888 | $5,812 | 0.2% | |
| Advertising and promotion | $1,882 | $1,468 | $414 | - | 0.0% | |
| Total | $72,838,428 | 100% |
2011 · Form 990 · $70,673,639 spent · pay $29,551,806 · grants $0 · events $78,335
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,098,202 | $17,336,344 | $2,173,266 | $588,592 | 28.4% | |
| Other (as described) | LAB SUPPLIES | $8,316,677 | $8,316,677 | - | - | 11.8% |
| Depreciation and depletion | $7,998,395 | $4,326,286 | $3,672,109 | - | 11.3% | |
| Other employee benefits | $5,086,381 | $4,613,963 | $319,791 | $152,627 | 7.2% | |
| Other (as described) | FELLOWSHIPS | $4,367,345 | $4,322,947 | $44,398 | - | 6.2% |
| All other expenses | $3,359,697 | $2,544,130 | $800,141 | $15,426 | 4.8% | |
| Occupancy | $2,966,191 | $2,529,086 | $437,105 | - | 4.2% | |
| Fees: investment management | $2,673,307 | - | $2,673,307 | - | 3.8% | |
| Other (as described) | EQUIP PURCH/RENT REPAIR MAIN | $2,233,315 | $1,561,951 | $660,915 | $10,449 | 3.2% |
| Royalties | $2,060,506 | $2,060,506 | - | - | 2.9% | |
| Interest | $1,980,360 | $1,683,306 | $297,054 | - | 2.8% | |
| Other (as described) | RESEARCH SUBCONTRACTS | $1,944,340 | $1,944,340 | - | - | 2.8% |
| Pension plan contributions | $1,864,680 | $1,608,439 | $201,632 | $54,609 | 2.6% | |
| Payroll taxes | $1,458,834 | $1,258,364 | $157,747 | $42,723 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $1,043,709 | $128,950 | $914,759 | - | 1.5% | |
| Office expenses | $911,224 | $731,752 | $157,519 | $21,953 | 1.3% | |
| Information technology | $671,410 | $475,225 | $190,089 | $6,096 | 1.0% | |
| Travel | $483,052 | $395,214 | $66,403 | $21,435 | 0.7% | |
| Fees: accounting | $447,937 | - | $447,937 | - | 0.6% | |
| Fees: other services | $390,740 | $269,427 | $119,886 | $1,427 | 0.6% | |
| Insurance | $141,732 | - | $141,732 | - | 0.2% | |
| Fees: legal | $86,393 | - | $86,393 | - | 0.1% | |
| Conferences, conventions and meetings | $78,335 | $70,151 | $4,764 | $3,420 | 0.1% | |
| Advertising and promotion | $10,877 | $8,484 | $2,393 | - | 0.0% | |
| Total | $70,673,639 | 100% |
2010 · Form 990 · $69,328,486 spent · pay $28,525,945 · grants $0 · events $584,772
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,221,109 | $13,204,300 | $5,574,212 | $442,597 | 27.7% | |
| Other (as described) | LAB SUPPLIES AND EQUIPMENT | $8,732,103 | $8,732,103 | - | - | 12.6% |
| Depreciation and depletion | $8,203,513 | $3,347,092 | $4,856,421 | - | 11.8% | |
| Other employee benefits | $5,227,165 | $3,590,899 | $1,515,902 | $120,364 | 7.5% | |
| Other (as described) | FELLOWSHIPS | $4,499,298 | $4,448,222 | $51,076 | - | 6.5% |
| Occupancy | $3,090,871 | $1,300,219 | $1,790,652 | - | 4.5% | |
| Fees: investment management | $2,499,741 | - | $2,499,741 | - | 3.6% | |
| Other (as described) | EQUIP. PURCH/RENT REPAIR MAINT | $1,823,174 | $868,319 | $952,559 | $2,296 | 2.6% |
| Other (as described) | ANIMAL CARE | $1,705,889 | $1,705,889 | - | - | 2.5% |
| Pension plan contributions | $1,675,382 | $1,158,150 | $477,468 | $39,764 | 2.4% | |
| Other (as described) | RESEARCH SUBCONTRACTS | $1,661,521 | $1,661,521 | - | - | 2.4% |
| All other expenses | $1,457,934 | $1,046,055 | $409,261 | $2,618 | 2.1% | |
| Payroll taxes | $1,392,686 | $934,034 | $426,583 | $32,069 | 2.0% | |
| Fees: legal | $1,346,224 | $4,940 | $1,341,102 | $182 | 1.9% | |
| Interest | $1,217,011 | $721,289 | $495,722 | - | 1.8% | |
| Royalties | $1,080,647 | - | $1,080,647 | - | 1.6% | |
| Pay: officers, directors, trustees, key employees | $1,009,603 | - | $1,009,603 | - | 1.5% | |
| Fees: accounting | $950,423 | - | $950,423 | - | 1.4% | |
| Office expenses | $674,925 | $260,616 | $363,851 | $50,458 | 1.0% | |
| Conferences, conventions and meetings | $584,772 | $129,123 | $422,245 | $33,404 | 0.8% | |
| Information technology | $524,049 | $260,776 | $239,276 | $23,997 | 0.8% | |
| Travel | $449,446 | $341,960 | $93,754 | $13,732 | 0.6% | |
| Fees: other services | $169,836 | $95,251 | $69,465 | $5,120 | 0.2% | |
| Insurance | $122,426 | - | $122,426 | - | 0.2% | |
| Advertising and promotion | $8,738 | - | $8,738 | - | 0.0% | |
| Total | $69,328,486 | 100% |
2009 · Form 990 · $76,732,724 spent · pay $27,437,419 · grants $0 · events $190,848
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,052,175 | $13,270,710 | $6,520,078 | $261,387 | 26.1% | |
| Other (as described) | LAB SUPPLIES AND EQUIPMENT | $9,137,665 | $8,896,638 | $241,027 | - | 11.9% |
| Depreciation and depletion | $7,294,709 | $4,717,984 | $2,550,475 | $26,250 | 9.5% | |
| Fees: legal | $7,268,240 | - | $7,268,240 | - | 9.5% | |
| Occupancy | $4,104,309 | $2,365,448 | $1,728,467 | $10,394 | 5.3% | |
| Other employee benefits | $3,366,421 | $2,341,624 | $996,170 | $28,627 | 4.4% | |
| Fees: other services | $3,255,525 | $2,514,706 | $705,562 | $35,257 | 4.2% | |
| Fees: investment management | $3,206,487 | - | $3,206,487 | - | 4.2% | |
| Other (as described) | FELLOWSHIPS | $2,654,264 | $2,654,264 | - | - | 3.5% |
| Other (as described) | RESEARCH SUBCONTRACTS | $2,444,318 | $2,444,318 | - | - | 3.2% |
| Other (as described) | TUITION | $2,422,751 | $2,414,271 | $8,480 | - | 3.2% |
| Office expenses | $2,141,043 | $1,469,747 | $653,952 | $17,344 | 2.8% | |
| Pension plan contributions | $1,725,819 | $1,153,243 | $548,938 | $23,638 | 2.2% | |
| Payroll taxes | $1,390,465 | $929,766 | $442,398 | $18,301 | 1.8% | |
| Interest | $1,321,558 | $1,208,272 | $113,286 | - | 1.7% | |
| All other expenses | $1,187,348 | $600,459 | $574,901 | $11,988 | 1.5% | |
| Royalties | $959,447 | $959,447 | - | - | 1.3% | |
| Pay: officers, directors, trustees, key employees | $902,539 | - | $902,539 | - | 1.2% | |
| Information technology | $408,076 | $368,084 | $37,181 | $2,811 | 0.5% | |
| Travel | $380,112 | $283,971 | $84,755 | $11,386 | 0.5% | |
| Advertising and promotion | $350,180 | $128,944 | $213,980 | $7,256 | 0.5% | |
| Other (as described) | DEBT ISSUANCE/AMORTIZATION | $205,096 | - | $205,096 | - | 0.3% |
| Conferences, conventions and meetings | $190,848 | $145,011 | $44,619 | $1,218 | 0.2% | |
| Insurance | $185,427 | - | $185,427 | - | 0.2% | |
| Fees: accounting | $177,182 | - | $177,182 | - | 0.2% | |
| Fees: lobbying | $720 | $720 | - | - | 0.0% | |
| Total | $76,732,724 | 100% |
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $14,313,167 | $0 | 31 |
| 2025 | $10,457,774 | $0 | 29 |
| 2024 | $10,705,345 | $0 | 33 |
| 2023 | $11,226,253 | $0 | 35 |
| 2022 | $13,908,628 | $0 | 37 |
| 2021 | $10,955,270 | $0 | 43 |
| 2020 | $11,492,257 | $0 | 36 |
| 2019 | $9,223,617 | $0 | 44 |
| 2018 | $15,651,859 | $0 | 43 |
| 2017 | $18,311,121 | $0 | 61 |
| 2016 | $1,320,527 | $0 | 3 |
| 2015 | $5,868,335 | $8,943 | 6 |
| 2014 | $3,151,746 | $0 | 6 |
| 2013 | $1,354,603 | $0 | 5 |
| 2012 | $1,419,883 | $0 | 4 |
| 2011 | $1,112,646 | $0 | 3 |
| 2010 | $585,117 | $0 | 2 |
| 2009 | $1,688,677 | $8,382,261 | 8 |
| 2008 | $1,972,750 | $0 | 5 |
| 2007 | $943,922 | $5,860,254 | 3 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL GENE REGULATION | $3,779,457 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | CENTER FOR GENOME EDITING AND RECORDING | $2,450,002 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | LEVERAGING CELL-DERIVED BIOPARTICLES FOR MACROMOLECULAR DELIVERY - 7. PROJECT SUMMARY/ABSTRACT MANY EMERGING THERAPEUTIC STRATEGIES EMPLOY MACROMOLECULES, LIKE | $1,462,500 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONTROL OF HOST INVASION BY PROTEIN COMPLEXES CONSERVED ACROSS APICOMPLEXAN PARASITES - 7. PROJECT SUMMARY/ABSTRACT HOW APICOMPLEXAN PARASITES RECOGNIZE HOST CE | $899,850 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | TRANSCRIPTIONAL REGULATION IN MAMMALIAN CELLS - PROJECT SUMMARY/ABSTRACT TRANSCRIPTION IS A FUNDAMENTAL CELLULAR PROCESS WHOSE PROPER REGULATION IS ESSENTIAL T | $798,507 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $793,650 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | PROJECT ILLUMINE - EXPLOITING THE DARK PROTEOME TO FIGHT CANCER - ABSTRACT CELLS PRODUCE A PREVIOUSLY UNDER-APPRECIATED CLASS OF NON-STANDARD PROTEINS COLLECTIV | $781,718 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | FUNCTION AND MECHANISMS OF EPIGENETIC STABILITY AND DYNAMICS IN ARABIDOPSIS - PROJECT SUMMARY/ABSTRACT EPIGENETIC MODIFICATIONS REGULATE GENOME FUNCTION. MY RES | $487,500 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY MECHANISMS IN PLANARIANS - PROJECT SUMMARY THE CAPACITY TO REGULATE STEM AND PROGENITOR CELLS FOR REGENERATION IS WIDESPRE | $487,500 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ELUCIDATING THE MOLECULAR AND CELLULAR FUNCTIONS OF POLYAMINES - PROJECT SUMMARY POLYAMINES ARE SMALL ORGANIC COMPOUNDS WITH TWO OR MORE AMINE GROUPS. THESE EVO | $487,500 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | DECODING FUNCTIONAL CELL-CELL COMMUNICATION TO UNCOVER CELLULAR STATE MODULATION, TISSUE HOMEOSTASIS, AND DISEASE GENETICS - 7. PROJECT SUMMARY/ABSTRACT ALTHOUG | $487,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PROTECTING AND SUSTAINING GERM CELL IDENTITY - PROJECT SUMMARY/ABSTRACT GERM CELLS HAVE THE EXTRAORDINARY POTENTIAL TO GENERATE EVERY CELL TYPE IN THE BODY. YET | $419,250 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | EXPLORING TRANSCRIPTIONAL ADAPTATION: THERAPEUTIC POTENTIAL AND IMPACT ON HUMAN GENETICS - PROJECT SUMMARY/ABSTRACT MUTATIONS CAN LEAD TO A WIDE-VARIETY OF GENE | $178,416 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | SYSTEMATIC IDENTIFICATION AND MECHANISTIC CHARACTERIZATION OF NOVEL OXIDATIVE PROTECTIVE GENES TO PREVENT RPE DEGENERATION - PROJECT SUMMARY / ABSTRACT AGE-RELA | $173,016 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | COMBINATORIAL SIGNAL INTEGRATION IN THE MAINTENANCE AND RENEWAL OF ADULT GERMLINE STEM CELL FATE - PROJECT SUMMARY/ABSTRACT THROUGHOUT AN ORGANISM’S LIFETIME, A | $162,800 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | SPATIOTEMPORAL MAPPING OF TUMOR MICROENVIRONMENT EVOLUTION - PROJECT SUMMARY CANCER PROGRESSION AND THERAPEUTIC RESPONSE ARE STRONGLY INFLUENCED BY THE IMMUNE S | $141,750 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DECIPHERING THE REGULATORY LANDSCAPE OF UNTRANSLATED REGIONS ACROSS CELL TYPES - PROJECT SUMMARY UNDERSTANDING CELL TYPE-SPECIFIC PROTEIN EXPRESSION IS FUNDAME | $125,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SPATIALLY-RESOLVED, INTEGRATED CELL STATE AND LINEAGE TRACING TO DEFINE PROGENITOR CELL DYNAMICS IN EARLY MOUSE DEVELOPMENT - PROJECT SUMMARY: MAMMALIAN DEVELOP | $125,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISMS OF GENE EXPRESSION REGULATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PREDICTED TO BECOME THE SECOND DEADL | $112,172 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MECHANISMS GOVERNING POST-TRANSCRIPTIONAL REGULATION OF NEURONAL MICRORNAS - PROJECT SUMMARY MANY ASPECTS OF NEURAL PLASTICITY REQUIRE CHANGES IN GENE EXPRESSIO | $84,148 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DESIGNING NOVEL STRATEGIES TO TARGET TUMOR-PROMOTING FUNCTIONS OF PANCREATIC CANCER FIBROBLAST SUBTYPES | -$2,160 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DECIPHERING TRANSLATIONAL CONTROL IN STEM CELLS - PROJECT SUMMARY TRANSLATIONAL CONTROL IS CRITICAL FOR A VARIETY OF CELLULAR PROCESSES SUCH AS HOMEOSTASIS AND | -$13,755 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATING DIFFERENTIATION, MAINTENANCE, AND REACTIVATION OF THE TOXOPLASMA CHRONIC STAGE - 7. PROJECT SUMMARY/ABSTRACT TOXOPLASMA GONDII IS ONE OF THE MOST | -$27,162 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TUMOR AND IMMUNE CELL DYNAMICS DURING IMMUNOTHERAPY AND CANCER PROGRESSION - PROJECT SUMMARY TREATMENT OF CANCER HAS BEEN TRANSFORMED BY IMMUNOTHERAPIES THAT AI | -$80,989 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | CENTER FOR GENOME EDITING AND RECORDING | $2,450,000 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | BIOLOGY AND APPLICATIONS OF MAMMALIAN HIBERNATION-LIKE STATES - PROGRAM DIRECTOR/PRINCIPAL INVESTIGATOR (LAST, FIRST, MIDDLE): HRVATIN, SINISA PROJECT SUMMARY: | $1,170,000 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | TRANSCRIPTIONAL REGULATION IN MAMMALIAN CELLS - PROJECT SUMMARY/ABSTRACT TRANSCRIPTION IS A FUNDAMENTAL CELLULAR PROCESS WHOSE PROPER REGULATION IS ESSENTIAL T | $798,507 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $793,650 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL GENE REGULATION | $734,329 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPMENT AND MAINTENANCE OF CHRONIC TOXOPLASMOSIS - 7. PROJECT SUMMARY/ABSTRACT CHRONIC TOXOPLASMA GONDII INFECTIONS ARE WIDESPREAD AND THEIR REACTIVATION CA | $607,619 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ELUCIDATING THE MOLECULAR AND CELLULAR FUNCTIONS OF POLYAMINES - PROJECT SUMMARY POLYAMINES ARE SMALL ORGANIC COMPOUNDS WITH TWO OR MORE AMINE GROUPS. THESE EVO | $487,500 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY MECHANISMS IN PLANARIANS - PROJECT SUMMARY THE CAPACITY TO REGULATE STEM AND PROGENITOR CELLS FOR REGENERATION IS WIDESPRE | $487,500 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | FUNCTION AND MECHANISMS OF EPIGENETIC STABILITY AND DYNAMICS IN ARABIDOPSIS - PROJECT SUMMARY/ABSTRACT EPIGENETIC MODIFICATIONS REGULATE GENOME FUNCTION. MY RES | $487,500 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | LEVERAGING CELL-DERIVED BIOPARTICLES FOR MACROMOLECULAR DELIVERY - 7. PROJECT SUMMARY/ABSTRACT MANY EMERGING THERAPEUTIC STRATEGIES EMPLOY MACROMOLECULES, LIKE | $487,500 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | KRAS INHIBITORS PRIME CANCER CELLS FOR MACROPHAGE-MEDIATED DESTRUCTION - PROJECT SUMMARY APPROXIMATELY 20% OF ALL HUMAN CANCERS CONTAIN A MUTATION IN THE KRAS O | $446,063 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PROTECTING AND SUSTAINING GERM CELL IDENTITY - PROJECT SUMMARY/ABSTRACT GERM CELLS HAVE THE EXTRAORDINARY POTENTIAL TO GENERATE EVERY CELL TYPE IN THE BODY. YET | $419,250 |
| 2025 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | EXPLORING TRANSCRIPTIONAL ADAPTATION: THERAPEUTIC POTENTIAL AND IMPACT ON HUMAN GENETICS - PROJECT SUMMARY/ABSTRACT MUTATIONS CAN LEAD TO A WIDE-VARIETY OF GENE | $178,416 |
| 2025 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | SYSTEMATIC IDENTIFICATION AND MECHANISTIC CHARACTERIZATION OF NOVEL OXIDATIVE PROTECTIVE GENES TO PREVENT RPE DEGENERATION - PROJECT SUMMARY / ABSTRACT AGE-RELA | $173,016 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | COMBINATORIAL SIGNAL INTEGRATION IN THE MAINTENANCE AND RENEWAL OF ADULT GERMLINE STEM CELL FATE - PROJECT SUMMARY/ABSTRACT THROUGHOUT AN ORGANISM’S LIFETIME, A | $162,800 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | THE WORLD’S SMALLEST VERTEBRATE BRAIN: A NEW MODEL FOR NERVOUS SYSTEM FUNCTION AND REGENERATION RESEARCH - PROJECT SUMMARY / ABSTRACT REGENERATION IS WIDESPREAD | $135,864 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | UNCOVERING THE MECHANISMS THAT PROMOTE AND MAINTAIN GERM CELL IDENTITY - PROJECT SUMMARY/ABSTRACT GERM CELLS HAVE THE POTENTIAL TO GENERATE EVERY CELL TYPE IN T | $135,864 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SPATIALLY-RESOLVED, INTEGRATED CELL STATE AND LINEAGE TRACING TO DEFINE PROGENITOR CELL DYNAMICS IN EARLY MOUSE DEVELOPMENT - PROJECT SUMMARY: MAMMALIAN DEVELOP | $125,000 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISMS OF GENE EXPRESSION REGULATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PREDICTED TO BECOME THE SECOND DEADL | $107,820 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATING DIFFERENTIATION, MAINTENANCE, AND REACTIVATION OF THE TOXOPLASMA CHRONIC STAGE - 7. PROJECT SUMMARY/ABSTRACT TOXOPLASMA GONDII IS ONE OF THE MOST | $80,224 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MECHANISMS GOVERNING POST-TRANSCRIPTIONAL REGULATION OF NEURONAL MICRORNAS - PROJECT SUMMARY MANY ASPECTS OF NEURAL PLASTICITY REQUIRE CHANGES IN GENE EXPRESSIO | $80,224 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL ORGANELLE CONTRIBUTION TO OFFSPRING GERMLINE HEALTH - PROJECT SUMMARY ORGANELLES ENGAGE IN HOMEOSTATIC PROCESSES TO IMPROVE CELLULAR HEALTH. HOWEVER, S | $75,520 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPI-GENETIC PROGRAMS IN CANCER PROGRESSION | $0 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | THE ROLE OF LYSOSOMAL DEREGULATION IN CANCER PROGRESSION | -$2,489 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REPROGRAMMING TOWARDS A GERMLINE STEM CELL FATE - PROJECT SUMMARY GERMLINE CELLULAR IMMORTALITY UNDERLIES THE CONTINUATION OF ALL SEXUALLY REPRODUCING SPECIES. | -$55,120 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TOWARDS PHARMACOLOGICAL RESCUE OF TSC LOSS OF FUNCTION | -$108,780 |
| 2024 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | CENTER FOR GENOME EDITING AND RECORDING | $2,449,998 |
| 2024 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | SYSTEMATIC RECONSTRUCTION OF EPITHELIAL-MESENCHYMAL COMMUNICATION IN ORGAN DEVELOPMENT - PROJECT SUMMARY MESENCHYMAL CELLS ARE MAJOR COMPONENTS OF TISSUE STROMA | $1,163,081 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | TRANSCRIPTIONAL REGULATION IN MAMMALIAN CELLS - PROJECT SUMMARY/ABSTRACT TRANSCRIPTION IS A FUNDAMENTAL CELLULAR PROCESS WHOSE PROPER REGULATION IS ESSENTIAL T | $798,507 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $793,650 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL GENE REGULATION | $734,329 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPMENT AND MAINTENANCE OF CHRONIC TOXOPLASMOSIS - 7. PROJECT SUMMARY/ABSTRACT CHRONIC TOXOPLASMA GONDII INFECTIONS ARE WIDESPREAD AND THEIR REACTIVATION CA | $642,884 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | FUNCTION AND MECHANISMS OF EPIGENETIC STABILITY AND DYNAMICS IN ARABIDOPSIS - PROJECT SUMMARY/ABSTRACT EPIGENETIC MODIFICATIONS REGULATE GENOME FUNCTION. MY RES | $487,500 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY MECHANISMS IN PLANARIANS - PROJECT SUMMARY THE CAPACITY TO REGULATE STEM AND PROGENITOR CELLS FOR REGENERATION IS WIDESPRE | $487,500 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONTROL OF PARASITE INVASION BY A MICRONEME PROTEIN COMPLEX CONSERVED IN APICOMPLEXANS | $487,500 |
| 2024 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | LEVERAGING CELL-DERIVED BIOPARTICLES FOR MACROMOLECULAR DELIVERY - 7. PROJECT SUMMARY/ABSTRACT MANY EMERGING THERAPEUTIC STRATEGIES EMPLOY MACROMOLECULES, LIKE | $487,500 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ELUCIDATING THE MOLECULAR AND CELLULAR FUNCTIONS OF POLYAMINES - PROJECT SUMMARY POLYAMINES ARE SMALL ORGANIC COMPOUNDS WITH TWO OR MORE AMINE GROUPS. THESE EVO | $487,500 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | KRAS INHIBITORS PRIME CANCER CELLS FOR MACROPHAGE-MEDIATED DESTRUCTION - PROJECT SUMMARY APPROXIMATELY 20% OF ALL HUMAN CANCERS CONTAIN A MUTATION IN THE KRAS O | $423,760 |
| 2024 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PROTECTING AND SUSTAINING GERM CELL IDENTITY - PROJECT SUMMARY/ABSTRACT GERM CELLS HAVE THE EXTRAORDINARY POTENTIAL TO GENERATE EVERY CELL TYPE IN THE BODY. YET | $415,058 |
| 2024 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | THE FUNCTION AND PROPERTIES OF RNA POLYMERASE IV IN SEED DEVELOPMENT | $382,869 |
| 2024 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | UNCOVERING THE MECHANISMS THAT PROMOTE AND MAINTAIN GERM CELL IDENTITY - PROJECT SUMMARY/ABSTRACT GERM CELLS HAVE THE POTENTIAL TO GENERATE EVERY CELL TYPE IN T | $135,864 |
| 2024 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | THE WORLD’S SMALLEST VERTEBRATE BRAIN: A NEW MODEL FOR NERVOUS SYSTEM FUNCTION AND REGENERATION RESEARCH - PROJECT SUMMARY / ABSTRACT REGENERATION IS WIDESPREAD | $135,864 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | GENETIC AND BIOPHYSICAL ANALYSIS OF MORPHOGEN GRADIENT FORMATION - PRINCIPAL INVESTIGATOR: SCHLISSEL, GAVIN PROJECT SUMMARY ANIMAL DEVELOPMENT AND PHYSIOLOGY RE | $125,000 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TUMOR AND IMMUNE CELL DYNAMICS DURING IMMUNOTHERAPY AND CANCER PROGRESSION - PROJECT SUMMARY TREATMENT OF CANCER HAS BEEN TRANSFORMED BY IMMUNOTHERAPIES THAT AI | $112,022 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISMS OF GENE EXPRESSION REGULATION IN PANCREATIC CANCER - PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS PREDICTED TO BECOME THE SECOND DEADL | $103,639 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | CHROMATIN AND IMMUNE REGULATION OF TUMOR GROWTH AND PROGRESSION - PROJECT SUMMARY LUNG AND PANCREATIC DUCTAL ADENOCARCINOMAS ARE OFTEN DIAGNOSED AT VERY LATE ST | $103,497 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | MECHANISMS GOVERNING POST-TRANSCRIPTIONAL REGULATION OF NEURONAL MICRORNAS - PROJECT SUMMARY MANY ASPECTS OF NEURAL PLASTICITY REQUIRE CHANGES IN GENE EXPRESSIO | $76,756 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATING DIFFERENTIATION, MAINTENANCE, AND REACTIVATION OF THE TOXOPLASMA CHRONIC STAGE - 7. PROJECT SUMMARY/ABSTRACT TOXOPLASMA GONDII IS ONE OF THE MOST | $76,756 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DECIPHERING TRANSLATIONAL CONTROL IN STEM CELLS - PROJECT SUMMARY TRANSLATIONAL CONTROL IS CRITICAL FOR A VARIETY OF CELLULAR PROCESSES SUCH AS HOMEOSTASIS AND | $76,756 |
| 2024 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL ORGANELLE CONTRIBUTION TO OFFSPRING GERMLINE HEALTH - PROJECT SUMMARY ORGANELLES ENGAGE IN HOMEOSTATIC PROCESSES TO IMPROVE CELLULAR HEALTH. HOWEVER, S | $73,828 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MECHANISMS OF MITOCHONDRIAL INHERITANCE - PROJECT SUMMARY THE SURVIVAL OF EUKARYOTIC SPECIES DEPENDS ON THE FAITHFUL TRANSMISSION OF BOTH NUCLEAR AND MITOCHONDR | -$639 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NEURONAL PATHWAYS REGULATING METABOLIC ADAPTATION | -$4,293 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | RNA-MEDIATED FEEDBACK CONTROL OF ONCOGENIC TRANSCRIPTION | -$11,407 |
| 2024 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | GERM CELL MIGRATION IN DROSOPHILA. | -$15,212 |
| 2024 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | PREDICTIVE MODELING OF MAMMALIAN CELL FATE TRANSITIONS OVER TIME AND SPACE WITH SINGLE-CELL GENOMICS - PROJECT SUMMARY DESPITE REMARKABLE ADVANCES IN SINGLE-CEL | -$37,093 |
| 2024 | National Institute of Food and Agriculture | Grant or other assistance | AGRICULTURE AND FOOD RESEARCH INITIATIVE (AFRI) 10.310 | HERBAL MEDICINE HAS BEEN DEVELOPED AND PRACTICED BY MULTIPLE INDIGENOUS CULTURES AROUND THE WORLD FOR MILLENNIA. IN MODERN MEDICINE, OF THE 175 THERAPEUTIC SMAL | -$487,626 |
| 2023 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | CENTER FOR GENOME EDITING AND RECORDING | $2,500,000 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPI-GENETIC PROGRAMS IN CANCER PROGRESSION | $1,146,600 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | GENETICALLY ENGINEERED HUMAN PLURIPOTENT STEM CELLS AS A PLATFORM TO DEFINE THE B | $881,324 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | TRANSCRIPTIONAL REGULATION IN MAMMALIAN CELLS - PROJECT SUMMARY/ABSTRACT TRANSCRIPTION IS A FUNDAMENTAL CELLULAR PROCESS WHOSE PROPER REGULATION IS ESSENTIAL T | $798,507 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $793,650 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL GENE REGULATION | $734,329 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPMENT AND MAINTENANCE OF CHRONIC TOXOPLASMOSIS - 7. PROJECT SUMMARY/ABSTRACT CHRONIC TOXOPLASMA GONDII INFECTIONS ARE WIDESPREAD AND THEIR REACTIVATION CA | $659,753 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | FUNCTION AND MECHANISMS OF EPIGENETIC STABILITY AND DYNAMICS IN ARABIDOPSIS - PROJECT SUMMARY/ABSTRACT EPIGENETIC MODIFICATIONS REGULATE GENOME FUNCTION. MY RES | $487,500 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ELUCIDATING THE MOLECULAR AND CELLULAR FUNCTIONS OF POLYAMINES - PROJECT SUMMARY POLYAMINES ARE SMALL ORGANIC COMPOUNDS WITH TWO OR MORE AMINE GROUPS. THESE EVO | $487,500 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY MECHANISMS IN PLANARIANS - PROJECT SUMMARY THE CAPACITY TO REGULATE STEM AND PROGENITOR CELLS FOR REGENERATION IS WIDESPRE | $487,500 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONTROL OF PARASITE INVASION BY A MICRONEME PROTEIN COMPLEX CONSERVED IN APICOMPLEXANS | $487,500 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | KRAS INHIBITORS PRIME CANCER CELLS FOR MACROPHAGE-MEDIATED DESTRUCTION - PROJECT SUMMARY APPROXIMATELY 20% OF ALL HUMAN CANCERS CONTAIN A MUTATION IN THE KRAS O | $446,063 |
| 2023 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PROTECTING AND SUSTAINING GERM CELL IDENTITY - PROJECT SUMMARY/ABSTRACT GERM CELLS HAVE THE EXTRAORDINARY POTENTIAL TO GENERATE EVERY CELL TYPE IN THE BODY. YET | $419,250 |
| 2023 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | THE FUNCTION AND PROPERTIES OF RNA POLYMERASE IV IN SEED DEVELOPMENT | $377,300 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | GENETIC AND BIOPHYSICAL ANALYSIS OF MORPHOGEN GRADIENT FORMATION - PRINCIPAL INVESTIGATOR: SCHLISSEL, GAVIN PROJECT SUMMARY ANIMAL DEVELOPMENT AND PHYSIOLOGY RE | $125,000 |
| 2023 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | PREDICTIVE MODELING OF MAMMALIAN CELL FATE TRANSITIONS OVER TIME AND SPACE WITH SINGLE-CELL GENOMICS - PROJECT SUMMARY DESPITE REMARKABLE ADVANCES IN SINGLE-CEL | $122,138 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | THE ROLE OF LYSOSOMAL DEREGULATION IN CANCER PROGRESSION | $105,985 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TUMOR AND IMMUNE CELL DYNAMICS DURING IMMUNOTHERAPY AND CANCER PROGRESSION - PROJECT SUMMARY TREATMENT OF CANCER HAS BEEN TRANSFORMED BY IMMUNOTHERAPIES THAT AI | $100,486 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REPROGRAMMING TOWARDS A GERMLINE STEM CELL FATE - PROJECT SUMMARY GERMLINE CELLULAR IMMORTALITY UNDERLIES THE CONTINUATION OF ALL SEXUALLY REPRODUCING SPECIES. | $71,792 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DECIPHERING TRANSLATIONAL CONTROL IN STEM CELLS - PROJECT SUMMARY TRANSLATIONAL CONTROL IS CRITICAL FOR A VARIETY OF CELLULAR PROCESSES SUCH AS HOMEOSTASIS AND | $69,500 |
| 2023 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL ORGANELLE CONTRIBUTION TO OFFSPRING GERMLINE HEALTH - PROJECT SUMMARY ORGANELLES ENGAGE IN HOMEOSTATIC PROCESSES TO IMPROVE CELLULAR HEALTH. HOWEVER, S | $66,790 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MECHANISMS OF MITOCHONDRIAL INHERITANCE - PROJECT SUMMARY THE SURVIVAL OF EUKARYOTIC SPECIES DEPENDS ON THE FAITHFUL TRANSMISSION OF BOTH NUCLEAR AND MITOCHONDR | $2,500 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | RNA GELATION IN REPEAT EXPANSION DISORDERS | $0 |
| 2023 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SPATIO-TEMPORAL SIGNALING DYNAMICS IN NEURONAL CELL FATE DECISION AND PATTERNING | $0 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY GENES IN PLANARIANS | -$1,684 |
| 2023 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | ESTABLISHMENT OF THE MEIOTIC CELL CYCLE PROGRAM THROUGH POST-TRANSCRIPTIONAL REGULATION BY MEIOC AND YTHDC2 | -$5,689 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | METABOLIC RECYCLING AND COMPARTMENTALIZATION IN TUMOR PROGRESSION | -$59,260 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISTIC INSIGHTS INTO LYSOSOMAL NUTRIENT EFFLUX IN CANCER - ABSTRACT MANY RAS-TRANSFORMED AGGRESSIVE CANCER CELLS ARE ABLE TO ESCAPE CYTOTOXIC CHEMOTHERAPY | -$78,079 |
| 2022 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | CENTER FOR GENOME EDITING AND RECORDING | $2,500,000 |
| 2022 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | BIOLOGY AND APPLICATIONS OF MAMMALIAN HIBERNATION-LIKE STATES - PROGRAM DIRECTOR/PRINCIPAL INVESTIGATOR (LAST, FIRST, MIDDLE): HRVATIN, SINISA PROJECT SUMMARY: | $1,755,000 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPI-GENETIC PROGRAMS IN CANCER PROGRESSION | $1,146,600 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | GENETICALLY ENGINEERED HUMAN PLURIPOTENT STEM CELLS AS A PLATFORM TO DEFINE THE B | $892,575 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | TRANSCRIPTIONAL REGULATION IN MAMMALIAN CELLS - PROJECT SUMMARY/ABSTRACT TRANSCRIPTION IS A FUNDAMENTAL CELLULAR PROCESS WHOSE PROPER REGULATION IS ESSENTIAL T | $798,507 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL GENE REGULATION | $734,329 |
| 2022 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IDENTIFYING CYTOKINES THAT ENHANCE MACROPHAGE IMMUNOTHERAPY OF COLORECTAL CANCER | $731,250 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $721,500 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPMENT AND MAINTENANCE OF CHRONIC TOXOPLASMOSIS - 7. PROJECT SUMMARY/ABSTRACT CHRONIC TOXOPLASMA GONDII INFECTIONS ARE WIDESPREAD AND THEIR REACTIVATION CA | $671,297 |
| 2022 | National Institute of Food and Agriculture | Grant or other assistance | AGRICULTURE AND FOOD RESEARCH INITIATIVE (AFRI) 10.310 | HERBAL MEDICINE HAS BEEN DEVELOPED AND PRACTICED BY MULTIPLE INDIGENOUS CULTURES AROUND THE WORLD FOR MILLENNIA. IN MODERN MEDICINE, OF THE 175 THERAPEUTIC SMAL | $638,000 |
| 2022 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DESIGNING NOVEL STRATEGIES TO TARGET TUMOR-PROMOTING FUNCTIONS OF PANCREATIC CANCER FIBROBLAST SUBTYPES | $585,000 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONTROL OF PARASITE INVASION BY A MICRONEME PROTEIN COMPLEX CONSERVED IN APICOMPLEXANS | $487,500 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | FUNCTION AND MECHANISMS OF EPIGENETIC STABILITY AND DYNAMICS IN ARABIDOPSIS - PROJECT SUMMARY/ABSTRACT EPIGENETIC MODIFICATIONS REGULATE GENOME FUNCTION. MY RES | $487,500 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY MECHANISMS IN PLANARIANS - PROJECT SUMMARY THE CAPACITY TO REGULATE STEM AND PROGENITOR CELLS FOR REGENERATION IS WIDESPRE | $487,500 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DEFINING THE SIGNALING PATHWAYS THAT DIRECT ADULT TISSUE STEM CELLS TO EXIT MULTIPOTENCY | $419,321 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NEURONAL PATHWAYS REGULATING METABOLIC ADAPTATION | $158,414 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISTIC INSIGHTS INTO LYSOSOMAL NUTRIENT EFFLUX IN CANCER - ABSTRACT MANY RAS-TRANSFORMED AGGRESSIVE CANCER CELLS ARE ABLE TO ESCAPE CYTOTOXIC CHEMOTHERAPY | $115,080 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | METABOLIC RECYCLING AND COMPARTMENTALIZATION IN TUMOR PROGRESSION | $105,154 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | THE ROLE OF LYSOSOMAL DEREGULATION IN CANCER PROGRESSION | $101,134 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TUMOR AND IMMUNE CELL DYNAMICS DURING IMMUNOTHERAPY AND CANCER PROGRESSION - PROJECT SUMMARY TREATMENT OF CANCER HAS BEEN TRANSFORMED BY IMMUNOTHERAPIES THAT AI | $95,669 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | RNA-MEDIATED FEEDBACK CONTROL OF ONCOGENIC TRANSCRIPTION | $71,734 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MECHANISMS OF MITOCHONDRIAL INHERITANCE - PROJECT SUMMARY THE SURVIVAL OF EUKARYOTIC SPECIES DEPENDS ON THE FAITHFUL TRANSMISSION OF BOTH NUCLEAR AND MITOCHONDR | $69,802 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REPROGRAMMING TOWARDS A GERMLINE STEM CELL FATE - PROJECT SUMMARY GERMLINE CELLULAR IMMORTALITY UNDERLIES THE CONTINUATION OF ALL SEXUALLY REPRODUCING SPECIES. | $67,582 |
| 2022 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | ESTABLISHMENT OF THE MEIOTIC CELL CYCLE PROGRAM THROUGH POST-TRANSCRIPTIONAL REGULATION BY MEIOC AND YTHDC2 | $63,396 |
| 2022 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | CONFERENCE: GORDON RESEARCH CONFERENCE IN CENTROMERE BIOLOGY -CENTROMERES REMAIN PERHAPS THE MOST ENIGMATIC REGIONS OF THE EUKARYOTIC GENOME, DESPITE THEIR CRIT | $17,500 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CELL GROWTH SIGNALING IN CANCER DEVELOPMENT | $0 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATION OF DNA METHYLATION HOMEOSTASIS IN ARABIDOPSIS | -$2 |
| 2022 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | REGULATION OF THE CELL CYCLE DURING MEIOTIC PROPHASE I BY MEIOC | -$2,191 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | UNDERSTANDING MIRNA-TARGET RECOGNITION THROUGH COMPREHENSIVE AFFINITY AND REPRESSION MEASUREMENTS | -$10,520 |
| 2021 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | SYSTEMATIC RECONSTRUCTION OF EPITHELIAL-MESENCHYMAL COMMUNICATION IN ORGAN DEVELOPMENT - PROJECT SUMMARY MESENCHYMAL CELLS ARE MAJOR COMPONENTS OF TISSUE STROMA | $1,755,000 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPI-GENETIC PROGRAMS IN CANCER PROGRESSION | $1,170,000 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | GENETICALLY ENGINEERED HUMAN PLURIPOTENT STEM CELLS AS A PLATFORM TO DEFINE THE B | $903,497 |
| 2021 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | THE FUNCTION AND PROPERTIES OF RNA POLYMERASE IV IN SEED DEVELOPMENT | $736,207 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $721,500 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPMENT AND MAINTENANCE OF CHRONIC TOXOPLASMOSIS - 7. PROJECT SUMMARY/ABSTRACT CHRONIC TOXOPLASMA GONDII INFECTIONS ARE WIDESPREAD AND THEIR REACTIVATION CA | $682,500 |
| 2021 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | ZEISS LSM 980 WITH AIRYSCAN 2 CONFOCAL MICROSCOPE SYSTEM - PROJECT SUMMARY/ABSTRACT THE WHITEHEAD INSTITUTE REQUESTS $600,000 FOR THE PURCHASE OF A CRITICALLY-N | $600,000 |
| 2021 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | DELINEATING GENETIC RISK TO ADDICTION VIA ANALYSIS OF 3D CHROMATIN ARCHITECTURE | $555,750 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DEFINING MOLECULAR SIGNATURES UNDERLYING LYSOSOMAL DYSFUNCTION IN ALZHEIMER?S DISEASE - LYSOSOMES ARE MEMBRANE-BOUND DEGRADATIVE COMPARTMENTS THAT BREAK DOWN MA | $536,250 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RAPAMYCIN-INSENSITIVE SIGNALING BY RICTOR-MTOR | $487,500 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONTROL OF PARASITE INVASION BY A MICRONEME PROTEIN COMPLEX CONSERVED IN APICOMPLEXANS | $487,500 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CELL GROWTH SIGNALING IN CANCER DEVELOPMENT | $463,125 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | REGULATION OF THE MTOR GROWTH PATHWAY BY NUTRIENTS | $416,813 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EXPLOITING MITOCHONDRIAL HETEROPLASMY FOR CANCER CHEMOTHERAPY | $390,000 |
| 2021 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TOWARDS PHARMACOLOGICAL RESCUE OF TSC LOSS OF FUNCTION | $292,500 |
| 2021 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SPATIO-TEMPORAL SIGNALING DYNAMICS IN NEURONAL CELL FATE DECISION AND PATTERNING | $238,448 |
| 2021 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | ESTABLISHMENT OF THE MEIOTIC CELL CYCLE PROGRAM THROUGH POST-TRANSCRIPTIONAL REGULATION BY MEIOC AND YTHDC2 | $136,755 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | MECHANISTIC INSIGHTS INTO LYSOSOMAL NUTRIENT EFFLUX IN CANCER - ABSTRACT MANY RAS-TRANSFORMED AGGRESSIVE CANCER CELLS ARE ABLE TO ESCAPE CYTOTOXIC CHEMOTHERAPY | $115,080 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | METABOLIC RECYCLING AND COMPARTMENTALIZATION IN TUMOR PROGRESSION | $100,343 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | THE ROLE OF LYSOSOMAL DEREGULATION IN CANCER PROGRESSION | $96,283 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | IDENTIFYING METABOLIC VULNERABILITIES IN PANCREATIC CANCER - PROJECT SUMMARY/ABSTRACT DESPITE RECENT ADVANCES IN CANCER TREATMENT, PANCREATIC CANCER (PDA) REMA | $92,470 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TUMOR AND IMMUNE CELL DYNAMICS DURING IMMUNOTHERAPY AND CANCER PROGRESSION - PROJECT SUMMARY TREATMENT OF CANCER HAS BEEN TRANSFORMED BY IMMUNOTHERAPIES THAT AI | $92,470 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | USING MITOCHONDRIAL DNA MUTATIONS TO UNDERSTAND LIMITATIONS OF MITOCHONDRIAL QUALITY CONTROL | $70,458 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | HUMAN INDUCED PLURIPOTENT STEM CELL MODELING OF GENETIC RISK FACTORS FOR ALZHEIMER'S DISEASE | $70,458 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | RNA-MEDIATED FEEDBACK CONTROL OF ONCOGENIC TRANSCRIPTION | $68,562 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MECHANISMS OF MITOCHONDRIAL INHERITANCE - PROJECT SUMMARY THE SURVIVAL OF EUKARYOTIC SPECIES DEPENDS ON THE FAITHFUL TRANSMISSION OF BOTH NUCLEAR AND MITOCHONDR | $66,390 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REPROGRAMMING TOWARDS A GERMLINE STEM CELL FATE - PROJECT SUMMARY GERMLINE CELLULAR IMMORTALITY UNDERLIES THE CONTINUATION OF ALL SEXUALLY REPRODUCING SPECIES. | $65,994 |
| 2021 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MOLECULAR CONTROL OF OOCYTE ARREST, MEIOSIS, AND THE TRANSITION TO DEVELOPMENT | $54,756 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ROLES FOR MRNA METHYLATION AND LNCRNA IN CANDIDA MATING AND PATHOGENICITY | -$25 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MODELING DNA METHYLATION CHANGES IN ALZHEIMER'S DISEASE USING INDUCED HUMAN PLURIPOTENT STEM CELLS. | -$560 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DEVELOPIN IN-VITRO MODELS OF A BETA TOXICITY: COMPLEMENTARY YEAST AND HUMAN STEM CELL APPROACHES | -$4,958 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | UNDERSTANDING THE HIGHLY DIVERGENT MITOCHONDRIAL ATP SYNTHASE IN T. GONDII | -$8,176 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | HOW EMBRYOS ESTABLISH A POSITIONAL MEMORY TO ENABLE ADULT REGENERATION. | -$9,850 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | HIV-1 RNA STRUCTURE EFFECTS ON LATENCY REVERSAL | -$24,616 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | UNDERSTANDING MIRNA-TARGET RECOGNITION THROUGH COMPREHENSIVE AFFINITY AND REPRESSION MEASUREMENTS | -$42,223 |
| 2021 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | DISCOVERY OF DRUGGABLE PATHWAYS THAT PREVENT CELL DEATH CAUSED BY PROTEOTOXIC STRESS | -$46,769 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | SUBSTRATES AND FUNCTIONS OF THE SIDEROFLEXIN MITOCHONDRIAL TRANSPORTER FAMILY | -$68,243 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MICORRNAS AND HEMATOPOIETIC DIFFERENTIATION | -$152,298 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | RNA GELATION IN REPEAT EXPANSION DISORDERS | -$153,621 |
| 2020 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | HARNESSING EVOLUTION TO REVEAL THE MOLECULAR LOGIC OF KINETOCHORE WIRING | $1,200,000 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EPI-GENETIC PROGRAMS IN CANCER PROGRESSION | $1,170,000 |
| 2020 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR ANALYSIS OF KINETOCHORE FUNCTION | $1,038,629 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | GENETICALLY ENGINEERED HUMAN PLURIPOTENT STEM CELLS AS A PLATFORM TO DEFINE THE B | $962,212 |
| 2020 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | TRANSCRIPTIONAL REGULATORY NETWORKS IN LIVING CELLS | $907,395 |
| 2020 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | POST-TRANSCRIPTIONAL GENE REGULATION | $712,941 |
| 2020 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | DELINEATING GENETIC RISK TO ADDICTION VIA ANALYSIS OF 3D CHROMATIN ARCHITECTURE | $555,750 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONTROL OF PARASITE INVASION BY A MICRONEME PROTEIN COMPLEX CONSERVED IN APICOMPLEXANS | $487,500 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RAPAMYCIN-INSENSITIVE SIGNALING BY RICTOR-MTOR | $487,500 |
| 2020 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | DISSECTING AND ENGINEERING REVERSIBLE CELL CYCLE STATES | $487,500 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | METABOLIC CHANGES UNDERLYING 16P11.2 DELETION SYNDROME | $467,750 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CELL GROWTH SIGNALING IN CANCER DEVELOPMENT | $463,125 |
| 2020 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | VERTEBRATE PRIMARY MOUTH FORMATION | $438,750 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | REGULATION OF THE MTOR GROWTH PATHWAY BY NUTRIENTS | $416,813 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | EXPLOITING MITOCHONDRIAL HETEROPLASMY FOR CANCER CHEMOTHERAPY | $390,000 |
| 2020 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STEM CELL AND REGENERATION REGULATORY GENES IN PLANARIANS | $377,910 |
| 2020 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | RNA GELATION IN REPEAT EXPANSION DISORDERS | $249,000 |
| 2020 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SPATIO-TEMPORAL SIGNALING DYNAMICS IN NEURONAL CELL FATE DECISION AND PATTERNING | $248,999 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPACT OF AGING ON INTESTINAL TUMORIGENESIS | $150,000 |
| 2020 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MOLECULAR CONTROL OF OOCYTE ARREST, MEIOSIS, AND THE TRANSITION TO DEVELOPMENT | $136,755 |
| 2020 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | ESTABLISHMENT OF THE MEIOTIC CELL CYCLE PROGRAM THROUGH POST-TRANSCRIPTIONAL REGULATION BY MEIOC AND YTHDC2 | $136,755 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | SUBSTRATES AND FUNCTIONS OF THE SIDEROFLEXIN MITOCHONDRIAL TRANSPORTER FAMILY | $107,999 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | METABOLIC RECYCLING AND COMPARTMENTALIZATION IN TUMOR PROGRESSION | $95,531 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | THE ROLE OF LYSOSOMAL DEREGULATION IN CANCER PROGRESSION | $93,053 |
State business registration
- WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH MA, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
The same business name in the same state, from the state’s official registry data.
Patents
176 US patents filed in the last 20 years; 1 security interest recorded against them.
- Whitehead Institute for Biomedical Research 176 patents, 2009-07-07 to 2026-10-13 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12760334 | Methods and compositions for efficient production of biofuels and bioplastics from toxic feedstocks | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12760328 | Compositions and methods for altering gene expression | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12747459 | System and method for increased alcohol tolerance and production in yeast | 2026-09-29 | PTBLXML, file of 2026-09-29 |
| US 12644889 | Viral condensates and methods of use thereof | 2026-06-02 | PTBLXML, file of 2026-06-02 |
| US 12605428 | Kinase NEK10 and its use in treating and diagnosing bronchiectasis and other respiratory disorders | 2026-04-21 | PTBLXML, file of 2026-04-21 |
| US 12577587 | Compositions and methods for mammalian genetics and uses thereof | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12454576 | Nanobody based imaging and targeting of ECM in disease and development | 2025-10-28 | PVGPATDIS, file of 2026-04-10 |
| US 12419940 | Compositions and methods for modified dendrimer nanoparticle delivery | 2025-09-23 | PVGPATDIS, file of 2026-04-10 |
| US 12385055 | Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2 | 2025-08-12 | PVGPATDIS, file of 2026-04-10 |
| US 12371667 | Enhanced methods for inducing and maintaining naive human pluripotent stem cells | 2025-07-29 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
2 US trademarks, 0 live.
- Whitehead Institute for Biomedical Research 2 marks, MA EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| (design) | 88822558 | 2020-03-05 | Abandoned | TRCFECO2, file of 2024-03-27 |
| WHITEHEAD INSTITUTE BRINGING DISCOVERY TO LIFE | 88822557 | 2020-03-05 | Abandoned | TRCFECO2, file of 2024-03-27 |
The newest marks of the trademark owners above, matched to this record by name (and state).
In the news
871 news articles name this organization (March 2015 to November 2026); the latest 10:
- MIT researchers traced the family history of over 1 million cells in developing mouse embryos; the map revealed when cells began becoming different organs
indiatimes.com, November 11, 2026 - Scientists create germ cell-supporting embryonic Sertoli-like cells from skin cells
engineeringevil.com, November 2, 2026 - Zuckerberg, Brin and Others Give Scientists $33M
nbcbayarea.com, November 1, 2026 - Capturing Complete Process Of Embryonic Development
miragenews.com, October 28, 2026 - Capturing the complete process of embryonic development
mit.edu, October 28, 2026 - Former MIT professor wins $6M in defamation lawsuit over sexual misconduct accusations
thecollegefix.com, October 20, 2026 - AI model decodes the language cells use to communicate
mit.edu, October 15, 2026 - AI Model Decodes Language Cells Use To Communicate
miragenews.com, October 15, 2026 - Cells use a little-known molecule to protect themselves from iron overload
mit.edu, August 26, 2026 - Cells Deploy Rare Molecule to Shield from Iron Overload
miragenews.com, August 25, 2026
News article metadata and links: The GDELT Project (https://www.gdeltproject.org/). Matched by: Exact name match: "whitehead institute for biomedical research". A shared name is not proof of the same organization; how the matching works. Most in the news.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | MA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | MA | Federal spending (USAspending) | name and state |
| Patent assignee | Whitehead Institute for Biomedical Research | MA | Patents (USPTO) | name and state |
| Trademark owner | Whitehead Institute for Biomedical Research | MA | Trademarks (USPTO) | name and state |
| Wikipedia article | Whitehead Institute | Wikipedia (English) | FUZZY: the same website address and the same name |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
NTEE code Biomedicine, Bioengineering Research, MA first:
- NATIONAL BIOMEDICAL RESEARCH FOUNDATION INC MA
- ARIJU INC MA
- GATEHOUSE BIO RESEARCH FOUNDATION I NC MA
- PIONEER VALLEY LIFE SCIENCES INSTITUTE OF BAYSTATE MEDICAL MA
- IXBIO INC MA
- SONA GLOBAL LIMITED MA
- JACKSON LABORATORY ME
- RESMED SLEEP DISORDERED BREATHING FOUNDATION CA
- FOUNDATION FOR BIOMEDICAL RESEARCH DC
- THE MASOOLI PROJECT INC CT
In other datasets, the same topic (Medical research) in MA:
- Form D issuer: 149 Medical, Inc. (Form D private offerings)
Interests: Biomedicine, Bioengineering Research · science:research_education · Medical research
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Census Tract 3523, Middlesex County, Massachusetts, place (city or town) Cambridge, MA, county Middlesex County, MA, state Massachusetts; placed by its ZIP code (county and tract) and city name (place). The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).
- DR RUTH LEHMANN was paid $1,081,921, 8.3 times the median household income in Cambridge, MA ($130,748), where 12.8% of residents live in poverty.
- Revenue of $222,267,487 is $1,871 per resident of Cambridge, MA (population 118,796).
- That revenue equals 3.44% of all household income in Cambridge, MA (49,444 households at the median $130,748, about $6,464,704,112).
- 368 employees is 3.1 per 1,000 residents of Cambridge, MA.
| Measure | Census tract Census Tract 3523, Middlesex County, Massachusetts | Place (city or town) Cambridge, MA | County Middlesex County, MA | State Massachusetts |
|---|---|---|---|---|
| Population B01003 | 4,877 | 118,796 | 1,638,365 | 7,044,056 |
| Population, 2020 census P1 | 4,313 | 118,403 | 1,632,002 | 7,029,917 |
| Median age B01002 | 32.2 | 30.4 | 38.9 | 40.0 |
| Under 18 B01001 | 14.2% | 12.4% | 19.5% | 19.4% |
| 65 and over B01001 | 6.9% | 12.2% | 16.3% | 17.9% |
| Households B11001 | 2,476 | 49,444 | 634,215 | 2,785,042 |
| Foreign born B05002 | 36.5% | 29.7% | 23.1% | 18.0% |
| Median household income B19013 | $171,633 | $130,748 | $130,847 | $103,960 |
| Median family income B19113 | $174,231 | $175,457 | $166,449 | $131,675 |
| Per capita income B19301 | $99,497 | $78,723 | $69,556 | $57,897 |
| Poverty rate B17001 | 4.6% | 12.8% | 7.7% | 10.0% |
| Unemployment rate B23025 | 0.4% | 3.4% | 4.4% | 5.2% |
| Civilian labor force B23025 | 3,538 | 73,493 | 946,989 | 3,911,446 |
| Mean commute (minutes) B08013 | 25.6 | 25.8 | 29.9 | 29.1 |
| Bachelor's degree or higher B15003 | 84.2% | 80.8% | 59.5% | 47.3% |
| Housing units B25001 | 2,833 | 54,840 | 664,267 | 3,030,406 |
| Owner-occupied B25003 | 12.7% | 33.5% | 61.3% | 62.5% |
| Renters B25003 | 87.3% | 66.5% | 38.7% | 37.5% |
| Median home value B25077 | $1,023,700 | $1,092,100 | $727,800 | $562,100 |
| Median gross rent B25064 | $3,501 | $2,787 | $2,201 | $1,762 |
| White, not Hispanic B03002 | 46.0% | 53.8% | 65.1% | 66.6% |
| Black B03002 | 15.7% | 10.3% | 4.7% | 6.4% |
| Hispanic or Latino B03002 | 3.4% | 8.8% | 9.3% | 13.3% |
| Asian B03002 | 29.4% | 20.2% | 13.6% | 7.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 3523, Middlesex County, Massachusetts.
Comments